Introduction {#s1}
============

In all eukaryotes, faithful chromosome duplication and segregation to the daughter cells is essential for cell viability and development. During mitosis, chromosomes bi-orient on the mitotic spindle, a structure made of microtubules, microtubule motors, and microtubule-binding proteins ([@bib24]). Chromosomes attach to spindle microtubules through large multisubunit assemblies known as kinetochores ([@bib43]). Besides microtubule binding, kinetochores harness a poorly understood molecular mechanism of 'error correction' that leads to selective stabilization of bi-oriented attachments ([@bib15]). Upon completion of bi-orientation, removal of sister chromatid cohesion allows the separation of the sister chromatids to the two newly forming daughter cells.

How kinetochores assemble, and how their position on chromosomes is maintained generation after generation, is an important and partly unresolved challenge. Kinetochores assemble on centromeres, unique chromosomal loci characterized by a strong enrichment of the histone H3 variant centromere protein A (CENP-A) ([@bib12]). Centromeres in different organisms often consist of long arrays of repetitive sequences, such as the human 171-basepair α-satellite repeats ([@bib20]; [@bib36]). However, centromeres are often found associated with non-repetitive and non-evolutionarily conserved sequences in different organisms. Furthermore, there are instances in humans and other species of neo-centromeres that become established on non-repetitive sequences ([@bib20]; [@bib36]). These examples indicate that the sequence of centromeric DNA contributes only marginally to centromere identity.

There is now general agreement that CENP-A itself is an epigenetic factor for specification of centromeres ([@bib4]; [@bib8]; [@bib54]). CENP-A is required for the recruitment of several inner (centromere-proximal) kinetochore proteins, now generally referred to as constitutive centromere associated network (CCAN) ([@bib17]; [@bib25]; [@bib27]; [@bib40]; [@bib42]), and thus acts as the kinetochore's foundation. CENP-A, together with other CCAN proteins, also promotes the recruitment of specialized machinery devoted to its own incorporation in chromatin ([@bib20]; [@bib36]). This limits incorporation of new CENP-A to the position of the existing CENP-A domain, thus preserving centromere identity. Importantly, the amount of CENP-A at centromeres is halved during DNA replication, and the ensuing CENP-A 'vacancy' may be filled with histone H3.3 ([@bib10]). The reduction in CENP-A is compensated with new CENP-A deposition after cell division, in the G1 phase of the cell cycle ([@bib1]; [@bib28]; [@bib49]), likely in a reaction that replaces H3.3 with CENP-A.

The Mis18 complex is an evolutionarily conserved functional unit of the CENP-A loading machinery ([@bib19]; [@bib22], [@bib23]). Vertebrate Mis18 complex consists of Mis18α and Mis18β, which are non-redundant and physically interacting paralogs, and M18BP1 (also known as KNL2) ([@bib19]). The Mis18 complex interacts with the CENP-A-specific chaperone HJURP ([@bib11]; [@bib16]; [@bib39]; [@bib61]) and with CCAN subunits ([@bib5]; [@bib26]; [@bib37]; [@bib50]; [@bib55]) ([Figure 1A](#fig1){ref-type="fig"}). Interactions of this machinery enable the recruitment of new CENP-A to already existing centromeres.10.7554/eLife.23352.002Figure 1.CDK1 regulates binding of M18BP1^1-140^ and Mis18α:Mis18β.(**A**) Simplified current model of the cell-cycle-dependent assembly of the CENP-A deposition machinery. CDKs phosphorylate CENP-A, HJURP, and M18BP1 to prevent the assembly of the protein complex during the S, G2, and M phases of the cell cycle. Reduced CDK activity in early G1 phase allows the CENP-A deposition machinery to interact and localize to centromeres through the interaction with subunits of CCAN. (**B**) Schematic diagrams of domain structures of M18BP1, Mis18α, and Mis18β. YP, Yippee domain; CH, C-terminal helix; αβBD, Mis18α:Mis18β binding domain. (**C**) Amylose-resin pull-down assays to identify the Mis18α:Mis18β-binding domain of M18BP1. M18BP1-MBP variants and MBP were produced in bacteria and Mis18α:Mis18β was produced using baculovirus co-expression system. Shown is a representative gel of pull-down assays that were repeated at least three times. The same applies to all other pull-down assays in this paper. (**D**) Sequence alignment of M18BP1^1-140^. Hs, *Homo sapiens*; Mm, *Mus musculus*; Bt, *Bos taurus*; Gg, *Gallus gallus*; Xl-1, *Xenopus laevis* isoform 1; Xl-2, *Xenopus laevis* isoform 2. Blue-boxed regions indicate putative CDK phosphorylation motifs. Residues that are identical in all sequences are shaded red, and residues that only have conserved substitutions are shaded yellow. (**E**) Amylose-resin pull-down assays examining how phosphorylation affects complex formation. MBP-M18BP1 variants were incubated with or without CDK1:Cyclin B1 at 30°C for 2 hr before mixing with Mis18α:Mis18β. The Phos-tag containing acrylamide gel was used to detect the mobility shift caused by phosphorylation. Gels in panels **C** and **E** were stained with CBB.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.002](10.7554/eLife.23352.002)10.7554/eLife.23352.003Figure 1---figure supplement 1.Previously identified phosphorylation sites on M18BP1.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.003](10.7554/eLife.23352.003)

M18BP1 is an 1132-residue protein whose sequence is predicted to be largely unstructured. It contains a conserved 50-residue SANT (Swi3, Ada2, N-CoR, and TFIIIB) domain and a 100-residue SANT-associated (SANTA) domain ([@bib3]; [@bib19]; [@bib33]; [@bib64]) ([Figure 1B](#fig1){ref-type="fig"}). The high content of unstructured regions suggests that M18BP1 functions as a hub for multiple protein-protein interactions. Indeed, CENP-C, CENP-I, Polo-like kinase 1 (Plk1), MgcRacGAP, and the histone acetyl transferase (HAT) KAT7 are suggested to interact with M18BP1 ([@bib5]; [@bib31]; [@bib35]; [@bib37]; [@bib41]; [@bib50]), but the molecular details of these interactions remain poorly defined.

On the other hand, significant progress has been made in the characterization of the interaction of M18BP1 with Mis18α and Mis18β. Mis18α and Mis18β have similar domain structures, with an N-terminal unstructured region, a Yippee domain in the middle region, and a C-terminal coiled-coil. Recent studies of the single *Schizosaccharomyces pombe* Mis18 ortholog and of the human Mis18α:Mis18β complex suggested that Mis18 proteins form tetramers ([@bib39]; [@bib56]). A segment of M18BP1 comprising \~380 N-terminal residues was shown to be responsible for a physical interaction with the Mis18α:Mis18β complex ([@bib41]; [@bib55]).

The assembly of the CENP-A deposition machinery in the G1 phase is regulated by inhibitory CDK phosphorylation of CENP-A ([@bib63]), HJURP ([@bib38]; [@bib61]), and M18BP1 ([@bib35]; [@bib52]). Moderate CDK activity through the S and G2 phases and high CDK activity in M phase of the cell cycle keep the CENP-A loading machinery disassembled ([@bib52]). Degradation of Cyclin B at anaphase and the ensuing decline in CDK activity reverts this condition, allowing physical interactions of the CENP-A loading machinery. The Mis18 complex starts localizing to the CENP-A domain from anaphase and recruits HJURP and new CENP-A in early G1 phase ([@bib11]; [@bib35]; [@bib39]). Functionally relevant CDK phosphorylation sites in CENP-A and HJURP were identified ([@bib38]; [@bib63]), but those in M18BP1 (show in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) remain functionally uncharacterized.

In this study, we report that two copies of M18BP1 bind an hexameric Mis18α:Mis18β complex, and that dimerization of M18BP1 is important for its recruitment to centromeres. We show that M18BP1 binds Mis18α:Mis18β through two sub-regions in its N-terminal 140 amino acids. Single CDK phosphorylation sites in each sub-region, Thr40 and Ser110, regulate the interaction, with phosphorylation largely reducing the affinity of M18BP1 for Mis18α:Mis18β, and phosphomimetic mutations abolishing the CENP-A loading activity of M18BP1. Thus, our results identify a mechanism to limit CENP-A loading to the G1 phase of the cell cycle.

Results {#s2}
=======

M18BP1^1--140^ contains two sequential binding regions for Mis18α:Mis18β {#s2-1}
------------------------------------------------------------------------

We performed amylose-resin pull-down assays with purified M18BP1-MBP (maltose binding protein) fusion variants and Mis18α:Mis18β to identify the M18BP1 sequence responsible for this interaction. The N-terminal 140 residues of M18BP1 were sufficient for Mis18α:Mis18β binding ([Figure 1C](#fig1){ref-type="fig"}. See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for a list of constructs used in this study), thus narrowing down the binding site for the Mis18α:Mis18β complex within the N-terminal region of M18BP1 ([@bib41]; [@bib55]). A sequence alignment of vertebrate M18BP1 ([Figure 1D](#fig1){ref-type="fig"}) revealed that the N-terminal 140 residues of M18BP1 contain two highly conserved CDK phosphorylation motifs at positions Thr40 and Ser110 that are surrounded by other conserved residues, and a less conserved CDK motif at position Thr4. Divergent sequences around residue 50--70 of M18BP1 create a gap separating the two conserved regions. To identify the region responsible for M18BP1 binding, we split M18BP1^1--140^ into two fragments (1--60 and 61--140). Both regions retained the ability to bind Mis18α:Mis18β, indicating that each region retains measurable binding affinity for Mis18α:Mis18β, with M18BP1^1--60^ binding apparently more strongly than M18BP1^61--140^ ([Figure 1E](#fig1){ref-type="fig"}). We performed pull-down assays with M18BP1 fragments that had been previously phosphorylated with recombinant human CDK1:Cyclin B1. Complete phosphorylation of the fragments was confirmed by mobility shift of the bands on Phos-tag gels. All phosphorylated M18BP1 fragments showed reduced binding affinity for Mis18α:Mis18β compared to the non-phosphorylated fragments ([Figure 1E](#fig1){ref-type="fig"}).

CENP-A loading assay in HeLa cells {#s2-2}
----------------------------------

We used the CRISPR/Cas9 system to create an in-frame 3' fusion of the SNAP-tag coding sequence with the endogenous CENP-A coding sequence in a HeLa Flp-In-T-REx cell line ([@bib58]). The resulting HeLa CENP-A-SNAP cell line allowed us to perform SNAP-pulse-labeling experiments to examine new CENP-A loading at centromeres ([@bib28]). HeLa CENP-A-SNAP cells were treated with M18BP1 siRNA ([@bib19]) for 48 hr and synchronized at different phases of the cell cycle using thymidine (G1/S transition), S-trityl-L-cysteine (STLC, mitosis), or mitotic-shake-off. Existing CENP-A-SNAP at the G1/S transition phase after thymidine treatment was blocked using SNAP-Cell Block reagent. After release in the cell cycle, newly loaded CENP-A-SNAP was eventually labeled after cells had transited through mitosis using SNAP-Cell 647-SiR in early G1 phase ([Figure 2A](#fig2){ref-type="fig"}). Cells treated with M18BP1 siRNA showed clear CENP-A loading defects, whereas control cells showed effective CENP-A loading ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Depletion of M18BP1 siRNA was quantitated using immunofluorescence from endogenous M18BP1 and Western blotting ([Figure 2---figure supplement 1B--C](#fig2s1){ref-type="fig"}).10.7554/eLife.23352.004Figure 2.Functional analysis of M18BP1^1--140^ and M18BP1^141--1132^ in CENP-A recruitment.(**A**) Schematic description of the experimental procedure for testing the functionality of M18BP1 variants for new CENP-A deposition and the recruitment of Mis18α to centromeres. SNAP-Cell Block was used to block existing CENP-A-SNAP proteins at the time point −10 hr, and SNAP-Cell 647-SiR was used to label newly produced CENP-A-SNAP at the time point +4 hr. (**B**--**D**) Representative images showing the fluorescence of CENP-A-SNAP labeled with SNAP-Cell 647-SiR (CENP-A-SNAP-SiR), mCherry-Mis18α and EGFP-M18BP1 variants in fixed HeLa cells treated as described in panel **A**. Centromeres were visualized with CREST sera. Control cells were treated with transfection reagent (Lipofectamine RNAiMAX) in the absence of M18BP1 siRNA. Scale bars represent 10 µm. DIC, differential interference contrast. All cell biological experiments in this paper were repeated at least three times. (**E**) Quantification of the fluorescence intensity of CENP-A-SNAP-SiR on each centromere. Centromere spots were detected using images of CREST channel with the software Fiji ([@bib47]). Mean intensity of CENP-A-SNAP-SiR fluorescence on centromeres was obtained from every experiment (\>100 centromere spots from 10--12 early G1 cells). The bar graph presents mean values from three independent experiments. Error bars indicate SEM. (**F**, **G**) Quantification of the fluorescence intensity of mCherry-Mis18α and EGFP-M18BP1 variants on each centromere.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.004](10.7554/eLife.23352.004)10.7554/eLife.23352.005Figure 2---figure supplement 1.HeLa CENP-A-SNAP cell lines.(**A**) Representative images showing the fluorescence of CENP-A-SNAP-SiR and the immunoflurorescence of M18BP1 in fixed HeLa cells treated as described in [Figure 2A](#fig2){ref-type="fig"}. Centromeres were visualized with CREST sera. Scale bars represent 10 µm. (**B**) Quantification of the immunofluorescence intensity of M18BP1 on each centromere. The mean intensity value of M18BP1 immunofluorescence of centromere spots from three independent experiments is presented (\>100 centromeres from 10 early G1 cells were quantified in one experiment). Error bars represent SEM (standard error of the mean). Centromeric M18BP1 level of the siRNA-treated cells was reduced to 16.6% of the level of the untreated cells. (**C**) Cell lysate (containing 50 µg protein) of HeLa CENP-A-SNAP cells treated with M18BP1 siRNA ([@bib19]) for 24 or 48 hr and the lysate of the control cells were analyzed using Western blotting with anti-M18BP1 antibody (Bethyl, A302-825A), anti-alpha-tubulin antibody (Sigma, T9026), and HRP-conjugated secondary antibodies (Amersham NXA931-1ML, NXA934-1ML). The intensity of protein bands corresponding to M18BP1 and tubulin were quantified from 16-bit image using the software Fiji. The comparison of the intensity ratio of M18BP1/tubulin are shown as percentages. Cellular M18BP1 level of the siRNA-treated cells was reduced to 20% of the level of the untreated cells after 48 hr siRNA treatment. (**D**) Cell lysate (containing 100 μg protei) of each HeLa cell line treated with 50 ng/ml doxycycline for 36 hr was analyzed using Western blotting with anti-GFP antibody (Abcam, AB6556), anti-alpha-tubulin antibody (Sigma, T9026), and HRP-conjugated secondary antibodies (Amersham NXA931-1ML, NXA934-1ML). DE, T40D/S110E.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.005](10.7554/eLife.23352.005)10.7554/eLife.23352.006Figure 2---figure supplement 2.Tandem 2A-peptide system enables efficient co-expression of multiple proteins in HeLa cells.(**A**) Schematic presentation showing the design of the co-expression vectors using 2A-peptides. The protein expression from the single ORF with the continuous coding sequence of EGFP-NLS (nuclear localization signal, PKKKRKV) ([@bib18]), P2A-T2A (or P2A, T2A alone), and mCherry-PTS1 (peroxisomal targeting signal--1, YKSKL) ([@bib34]) is regulated by CMV promoter and tetracycline operator. On translating the ORF sequence, ribosomes skip the synthesis of the glycyl-prolyl peptide bond at the C-terminus of a 2A peptide (indicated by red arrows) ([@bib6]; [@bib9]), which results in the separation of EGFP-NLS and mCherry-PTS1. Eighteen amino acids from P2A remain at the C-terminus of EGFP-NLS. Separated EGFP-NLS is expected to accumulate in the nucleus and mCherry-PTS1 in peroxisomes. (**B**) Representative images showing the fluorescence of EGFP-NLS and mCherry-PTS1 in fixed HeLa cells. HeLa cells were grown in DMEM supplemented with 10% tetracycline-free FBS and 2 mM L-glutamine at 37°C and treated with 50 ng/ml doxycycline for 24 hr for inducing protein expression. Green fluorescence of EGFP-NLS in peroxisomes indicates the presence of unseparated EGFP-NLS-mCherry-PTS1 product. (**C**) Cell lysates (containing 50 µg protein) of the HeLa cells expressing EGFP-NLS-P2AT2A-mCherry-PTS1 (or single P2A, T2A variants) were analyzed using Tricine--SDS-PAGE and imaged by EGFP fluorescence. Unseparated EGFP-NLS-mCherry-PTS1 product was detected only in the sample with single 2A-peptides. The 16-bit image was analyzed using the software Fiji to quantify the intensity of the bands. Separation efficiency = 100 × separated form/(separated form + unseparated form). (**D**) Western blot analyses of the same samples used in the experiment of panel **C**. The membrane with transferred proteins was cut into two pieces and immunoblotted using anti-GFP antibody (Abcam, AB6556), anti-vinculin antibody (Sigma, V9131), and HRP-conjugated secondary antibodies (Amersham NXA931-1ML, NXA934-1ML). The asterisk indicates unknown protein bands detected by the anti-GFP antibody. Black arrows in (**C**) and (**D**) indicate putative product of EGFP-NLS-P2A-T2A arisen from failure of separation at the cleavage site in P2A but not in T2A. (**E**) Representative images showing the fluorescence of MTS-TagBFP, EGFP-NLS and mCherry-PTS1 in the fixed HeLa cells. Twenty-nine-amino-acid mitochondrial targeting signal (MTS) from cytochrome *c* oxidase subunit 8A ([@bib45]) was fused to TagBFP and the fusion protein MTS-TagBFP was co-expressed with EGFP-NLS and mCherry-PTS1 using two P2A-T2A tandem peptides. Each fluorescent protein distributed in different cellular compartments without mislocalization.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.006](10.7554/eLife.23352.006)

Efficient co-expression with a modified 2A-peptide strategy {#s2-3}
-----------------------------------------------------------

Next, we wished to build an approach for testing different segments of M18BP1 for their ability to rescue kinetochore localization of Mis18α:Mis18β and CENP-A-SNAP incorporation in cells depleted of endogenous M18BP1. For this, we modified the 2A-peptide co-expression system to allow co-expression of EGFP-M18BP1 segments and of mCherry-Mis18α. 2A-peptides are 20-amino-acid viral peptides possessing 'ribosome skipping' activity and are widely used to co-express proteins in eukaryotic cells when introduced between coding sequences ([@bib7]; [@bib30]). P2A (Porcine Teschovirus-1 2A) and T2A (Thosea asigna virus 2A) are the most efficient of the known 2A-peptide sequences. However, both peptides used individually still result in incomplete 'ribosome skipping' ([@bib30]) ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}), and even 5--10% unseparated fusion proteins could mislead the interpretation of co-localization experiments.

To overcome this intrinsic limitation of 2A-peptides, we connected P2A and T2A in tandem ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). In test experiments, co-expression of EGFP-NLS and mCherry-PTS1 (directed to the nucleus and peroxisomes, respectively) with single P2A or T2A sequence separators resulted in a significant fraction of unseparated proteins and co-localization ([Figure 2---figure supplement 2B--D](#fig2s2){ref-type="fig"}). Co-expression with a tandem P2A-T2A construct, however, led to undetectable unseparated protein, and almost complete separation of the EGFP and mCherry signals in fluorescence microscopy experiments ([Figure 2---figure supplement 2B--D](#fig2s2){ref-type="fig"}). The same encouraging results were observed in a ternary expression that included an additional mitochondrial marker ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}).

We therefore fused a P2A-T2A tandem sequence in frame between full length EGFP-M18BP1 (EGFP-M18BP1^1--1132^) and mCherry-Mis18α. This rescue construct was stably integrated by Flp-In recombination into the CENP-A-SNAP HeLa Flp-In-T-REx cells. Doxycycline-induced expression of EGFP-M18BP1^1--1132^ rescued CENP-A-SNAP loading in cells depleted of endogenous M18BP1 ([Figure 2B,E](#fig2){ref-type="fig"}). In the same cells, mCherry-Mis18α showed centromere localization in G1 phase, indicating that EGFP-M18BP1^1--1132^ was also able to rescue Mis18α localization ([Figure 2B and F](#fig2){ref-type="fig"}).

Dominant-negative effect of M18BP1^1--140^ overexpression {#s2-4}
---------------------------------------------------------

We examined the effects of expressing the Mis18α:Mis18β-binding region of M18BP1 in the CENP-A-SNAP loading assay. HeLa cells expressing EGFP-M18BP1^1--140^ showed normal morphology but were unable to load new CENP-A-SNAP onto centromeres, regardless of whether endogenous M18BP1 had been depleted or not ([Figure 2C and E](#fig2){ref-type="fig"}). Both EGFP-M18BP1^1--140^ and mCherry-Mis18α failed to localize to centromeres, suggesting that EGFP-M18BP1^1--140^ has a strong dominant-negative effect on the function of endogenous M18BP1 ([Figure 2C, F and G](#fig2){ref-type="fig"}).

M18BP1^141--1132^ localizes to centromeres but is not sufficient for new CENP-A incorporation {#s2-5}
---------------------------------------------------------------------------------------------

We also examined the functionality of the M18BP1^141--1132^ construct, which lacks the Mis18α:Mis18β-binding region. HeLa cells expressing EGFP-M18BP1^141--1132^ showed a similar level of CENP-A-SNAP loading activity to the HeLa cells expressing EGFP-M18BP1^1--1132^ in presence of endogenous M18BP1, indicating that EGFP-M18BP1^141--1132^ does not exercise strong dominant-negative effects on endogenous M18BP1. However, no CENP-A-SNAP loading was observed when M18BP1 had been depleted, indicating that EGFP-M18BP1^141--1132^ cannot replace endogenous M18BP1 ([Figure 2D and E](#fig2){ref-type="fig"}). EGFP-M18BP1^141--1132^ weakly localized to centromeres, regardless of the depletion of endogenous M18BP1. However, no mCherry-Mis18α recruitment to the centromere was observed in presence of EGFP-M18BP1^141--1132^ (upon depletion of endogenous M18BP1), indicating that the interaction with M18BP1 is required for recruitment of Mis18α:Mis18β ([Figure 2D and G](#fig2){ref-type="fig"}).

Phosphorylation on M18BP1 Thr40 and Ser110 prevents Mis18α:Mis18β binding {#s2-6}
-------------------------------------------------------------------------

To confirm that Thr4, Thr40, and Ser110 are the major CDK-phosphorylation sites, we generated a series of non-phosphorylatable M18BP1 mutants by substituting Thr4, Thr40, and Ser110 with either Val or Ala and performed pull-down assays with Mis18α:Mis18β ([Figure 3A](#fig3){ref-type="fig"}). CDK1-treated T4V and T40V mutants of M18BP1^1-60^ showed reduced mobility shift, and a T4V/T40V double mutant of M18BP1^1--60^ showed no shift on Phos-tag gels, suggesting Thr4 and Thr40 are the major phosphorylation sites of M18BP1^1--60^. The interaction between M18BP1^1--60/T4V^ and Mis18α:Mis18β was sensitive to CDK-phosphorylation, while the interaction between M18BP1^1--60/T40V^ and Mis18α:Mis18β was not affected by CDK activity, indicating that phosphorylation of Thr40 is a determinant of the interaction. Applying the same strategy to the third site, Ser110, we found it to be the only major phosphorylation site within M18BP1^61--140^. We observed reduced affinity of M18BP1^61--140/S110A^ for Mis18α:Mis18β, but the interaction between M18BP1^61--140/S110A^ and Mis18α:Mis18β was clearly observed in the buffer containing 100 mM NaCl and was not affected by CDK activity. Combining T40V and S110A mutations, we were able to generate a mutant, M18BP1^1--140/T40V/S110A^, which was resistant to CDK activity ([Figure 3A](#fig3){ref-type="fig"}).10.7554/eLife.23352.007Figure 3.Phosphorylation on M18BP1 Thr40 and Ser110 reduces affinity for Mis18α:Mis18β.(**A**, **B**) Amylose-resin pull-down assays examining complex formation of Mis18α:Mis18β with non-phosphorylatable (panel **A**) or phosphomimetic (panel **B**) M18BP1 mutants. The experiments were performed as in [Figure 1C,E](#fig1){ref-type="fig"}. Binding buffer with 300 mM NaCl was used, unless indicated. WT, wild type.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.007](10.7554/eLife.23352.007)

We then generated a series of phosphomimetic-mutant M18BP1 fragments by substituting Thr4, Thr40, and Ser110 with either Asp or Glu. T4D and T4E mutants of M18BP1^1--60^ bound Mis18α:Mis18β as efficiently as the wild-type construct. T40E mutant of M18BP1^1--60^ showed reduced affinity for Mis18α:Mis18β, while the T40D mutant was unable to bind Mis18α:Mis18β. An S110E mutant of M18BP1^61--140^ showed stronger reduction of binding affinity for Mis18α:Mis18β than an S110D mutant. Combining the T40D and S110E mutations, we observed a reduction of the affinity of M18BP1^1--140/T40D/S110E^ for Mis18α:Mis18β comparable to that observed in presence of CDK1:Cyclin B1 ([Figures 3B](#fig3){ref-type="fig"} and [1E](#fig1){ref-type="fig"}).

Using the HeLa CENP-A-SNAP cell line, we determined that the effects of the M18BP1^1--1132/T40D/S110E^ on localization and CENP-A incorporation were similar to those observed in presence of EGFP-M18BP1^141--1132^. In both lines, we observed normal CENP-A-SNAP loading and localization of mCherry-Mis18α to centromeres in presence of endogenous M18BP1, but no CENP-A-SNAP loading nor localization of mCherry-Mis18α upon depletion of endogenous M18BP1 ([Figures 2D--G](#fig2){ref-type="fig"}, [4A and C--E](#fig4){ref-type="fig"}). When phosphomimetic mutations were introduced in the Mis18α:Mis18β-binding region (M18BP1^1--140/T40D/S110E^), the strong dominant-negative effects of M18BP1^1--140^ on CENP-A loading and mCherry-Mis18α localization were bypassed, suggesting that M18BP1^1--140/T40D/S110E^ cannot interact with Mis18α:Mis18β ([Figures 2C, E--G](#fig2){ref-type="fig"}, [4B and C--E](#fig4){ref-type="fig"}). In agreement with these findings and with our interpretation that M18BP1^1--140^ exercises a dominant-negative effect on CENP-A loading by binding to the the Mis18α:Mis18β complex complex, co-immunoprecipitation (co-IP) experiments with anti-GFP antibody coupled beads demonstrated that EGFP-M18BP1^1--140^, but not EGFP-M18BP1^1--140/T40D/S110E^, interacts with the Mis18α:Mis18β complex complex in HeLa cells ([Figure 4F](#fig4){ref-type="fig"}).10.7554/eLife.23352.008Figure 4.Functional analyses of M18BP1 T40D/S110E mutants in CENP-A recruitment.(**A**, **B**) Representative images showing the fluorescence of CENP-A-SNAP-SiR, mCherry-Mis18α, and EGFP-M18BP1 variants in fixed HeLa cells treated as described in [Figure 2A](#fig2){ref-type="fig"}. Centromeres were visualized with CREST sera. Scale bars represent 10 µm. (**C**--**E**) Quantification of the fluorescence intensity of CENP-A-SNAP-SiR (panel **C**), mCherry-Mis18α (panel **D**), or EGFP-M18BP1 variants (panel **E**) on each centromere. The quantification was performed and is presented in the same way described in the legend of [Figure 2E](#fig2){ref-type="fig"}. DE, T40D/S110E. (**F**) Western blots of co-immunoprecipitation experiments using GFP-Trap_A beads. HeLa CENP-A-SNAP + EGFP-M18BP1^1-140^-P2A-T2A-mCherry-Mis18α or EGFP-M18BP1^1-140/T40D/S110E^-P2A-T2A-mCherry-Mis18α were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.008](10.7554/eLife.23352.008)

The Mis18α:Mis18β complex is a hexamer {#s2-7}
--------------------------------------

We established a baculovirus system for co-expression of the Mis18α and Mis18β subunits and purified the complex to homogeneity. The Mis18α:Mis18β complex appeared monodisperse in size-exclusion chromatography (SEC) profiles ([Figure 5A](#fig5){ref-type="fig"}). We analyzed its stoichiometry with both sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation (AUC) ([Figure 5B--D](#fig5){ref-type="fig"}). We obtained molecular weight (MW) estimates of about 150 kD for the Mis18α:Mis18β complex from both AUC methods ([Figure 5B--D](#fig5){ref-type="fig"}). This corresponds to the predicted MW of a hexameric complex of Mis18α and Mis18β, but the stoichiometry remains unclear due to the similar size of the Mis18α and Mis18β subunits. To determine the stoichiometry of Mis18α and Mis18β within the complex, we tagged either Mis18α or Mis18β with MBP and purified two different complexes, 6His-Mis18α:MBP-Mis18β or MBP-Mis18α:6His-Mis18β ([Figure 5C](#fig5){ref-type="fig"}). The presence of each MBP in the complex increases the molecular mass of the complex by 42 kDa. The AUC results indicated unequivocally that 6His-Mis18α:MBP-Mis18β complex contains two MBPs and that MBP-Mis18α:6His-Mis18β complex contains four MBPs, thus demonstrating that the stoichiometry of the Mis18α:Mis18β complex is 4:2 ([Figure 5C--D](#fig5){ref-type="fig"}). Another notable feature of the Mis18α:Mis18β complex is an elongated conformation, as suggested by the early elution volume of SEC analysis and the high frictional ratio emerging from the AUC analysis in comparison to that of globular standard proteins ([@bib13]).10.7554/eLife.23352.009Figure 5.Determination of the stoichiometry of Mis18α:Mis18β complex.(**A**) Analytical SEC results of Mis18α:Mis18β (blue), 6His-Mis18α:MBP-Mis18β (green), MBP-Mis18α:6His-Mis18β (orange). The elution volumes of thyroglobulin (670 kD), ferritin (440 kD), and catalase (240 kD) are shown as standards. Red lines indicate fractions collected for Tricine--SDS-PAGE analyses. Gels were stained with CBB. (**B**) Sedimentation equilibrium AUC analysis of Mis18α:Mis18β. Results of data fitting of three datasets obtained at different protein concentrations are shown. Using the global fitting method of SEDPHAT together with four additional datasets ([Figure 5---figure supplement 1A--B](#fig5s1){ref-type="fig"}), we obtained the experimental MW of 153 kD. The values of root-mean-square deviation (RMSD) for data fitting are shown. (**C**) Sedimentation velocity AUC results of the same samples used in the analytical SEC experiments (panel A). The best-fit size distributions are shown with the colors indicated in panel A. Data profiles used for curve-fitting analyses are shown in [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}. (**D**) Summary table of the results obtained from the AUC experiments of panel B and **C**. Sed. coef., sedimentation coefficient; MW~obs~., observed molecular weight; MW~theo~., theoretical molecular weight; SV, sedimentation velocity; SE, sedimentation equilibrium.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.009](10.7554/eLife.23352.009)10.7554/eLife.23352.010Figure 5---figure supplement 1.Data profiles for AUC experiments.(**A**) Sedimentation equilibrium AUC data of Mis18α:Mis18β measured at 280 nm at the concentrations of 2 and 1 µM. (**B**) Sedimentation equilibrium AUC data of Mis18α:Mis18β measured at 230 nm at the concentrations of 1 and 0.5 µM. (**C**) Best-fitting results of the sedimentation velocity AUC data of Mis18α:Mis18β, 6His-Mis18α:MBP-Mis18β and MBP-Mis18α:6His-Mis18β. Residuals represent the deviation of the continuous *c*(*s*) distribution model from the observed signals. The values of root-mean-square deviation (RMSD) for data fitting are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.010](10.7554/eLife.23352.010)

Nardi and colleagues reported that purified full-length His-Mis18α and Strep-Mis18β form a hetero-tetramer when mixed at a 1:1 molar ratio ([@bib39]). Since their experiments were carried out with bacterially expressed proteins, whereas we used proteins expressed in insect cells, we asked if the inconsistency of hydrodynamic analyses resulted from differences in the host used for recombinant expression of the Mis18 complex. We therefore co-expressed 6His-Mis18α and MBP-Mis18β in *E. coli* with a bicistronic expression system. After removal of affinity tags, the *E. coli* and insect cell expressed Mis18α:Mis18β complexes showed essentially identical elution profiles in analytical SEC experiments at two different concentrations ([Figure 6A](#fig6){ref-type="fig"}). The two complexes also behaved essentially identically in sedimentation velocity AUC experiments ([Figure 6B--C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These results are in agreement with our contention that the Mis18 complex is hexameric. Untagged Mis18α and Mis18β were insoluble when expressed in isolation in *E. coli* (unpublished data), but tagging them with 6His-MBP delivered soluble products. 6His-MBP-Mis18β appeared monodisperse in analytical SEC experiments, whereas 6His-MBP-Mis18α appeared polydisperse, despite good purity ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Removing the 6His-MBP-tag without prior mixing of 6His-MBP-Mis18α and 6His-MBP-Mis18β caused precipitation of both Mis18α and Mis18β, indicative of poor stability of the individual untagged subunits. Tag cleavage after subunit mixing at 1:1 molar ratio yielded (in addition to a precipitate that was removed by centrifugation) Mis18α:Mis18β complex that eluted from an analytical SEC column at the same volume (\~1.45 ml) as the Mis18α:Mis18β complex obtained by co-expression in *E. coli* or insect cells ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}, compare with [Figure 6A](#fig6){ref-type="fig"}). Mixing 6His-MBP-Mis18α and 6His-MBP-Mis18β at 2:1 molar ratio and cleaving off the tags reduced precipitation and increased the final yield of soluble Mis18α:Mis18β complex, without changing the elution volume of the complex ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Finally, we repeated these SEC experiments using the detergent-containing SEC buffer reported by Nardi and colleagues ([@bib39]), again without observing significant changes in the elution profile of the Mis18α:Mis18β complex ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}).10.7554/eLife.23352.011Figure 6.Assembly mechanism of Mis18α:Mis18β-hexamer.(**A**) Analytical SEC results of insect-cell-expressed Mis18α:Mis18β (blue), *E. coli*-expressed Mis18α:Mis18β (green), Mis18α^1-191^:Mis18β^1-189^ (yellow-green), Mis18α^78-191^:Mis18β^73-189^ (orange), 6His-Mis18α^192-233^-mCherry:Mis18β^190-229^ (red), Mis18α^192-233^-mCherry:Mis18β^190-229^ (purple), 6His-Mis18α^192-233^:Mis18β^190-229^-MBP (black). SEC experiments were carried out with 10 µM protein (loading concentration), unless indicated in the figure. The elution volumes of thyroglobulin (670 kD), aldolase (158 kD), ovalbumin (44 kD), and myoglobin (17 kD) are shown as standards. Red lines indicate fractions collected for Tricine--SDS-PAGE analyses. Gels were stained with CBB, except the gel for 1 µM Mis18α:Mis18β (dashed green line), which was stained with SYPRO Ruby. Left-pointing arrowheads indicate degradation products of Mis18α^192-233^-mCherry. NT, N-terminal tail; YP, Yippee domain; CH, C-terminal helix; mCh, mCherry. (**B**) Sedimentation velocity AUC results of the same samples used in the analytical SEC experiments (panel **A**). The best-fit size distributions are shown with the colors indicated in panel **A**. Data profiles used for curve-fitting analyses are shown in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. (**C**) Summary table of the results obtained from the AUC experiments of panel **B**. Sed. coef., sedimentation coefficient; MW~obs~., observed molecular weight; MW~theo~., theoretical molecular weight. (**D**, **E**) Amylose-resin pull-down assays to examine the interaction of Mis18α:Mis18β variants with M18BP1^1-140^. Incubation of amylose beads and proteins (at 5 µM concentration) were performed using a binding buffer containing 30 mM HEPES pH 7.5, 100 mM NaCl, and 1 mM TCEP. Gels were stained with CBB. (**F**) Hypothetical assembly mechanism of the Mis18α:Mis18β-hexamer in mitosis and the octameric Mis18 complex in the early G1 phase.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.011](10.7554/eLife.23352.011)10.7554/eLife.23352.012Figure 6---figure supplement 1.Data profiles for AUC experiments.Best-fitting results of the sedimentation velocity AUC data of *E. coli*-expressed Mis18α:Mis18β, Mis18α^1--191^:Mis18β^1--189^, Mis18α^78--191^:Mis18β^73--189^, 6His-Mis18α^192--233^-mCherry:MBP-Mis18β^190--229^, Mis18α^192--233^-mCherry:Mis18β^190--229^, Mis18α^192--233^:MBP-Mis18β^190--229^. Residuals represent the deviation of the continuous *c*(*s*) distribution model from the observed signals. The values of RMSD for data fitting are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.012](10.7554/eLife.23352.012)10.7554/eLife.23352.013Figure 6---figure supplement 2.Generation of Mis18α:Mis18β complex by mixing 6His-MBP-Mis18α and 6His-MBP-Mis18β.(**A**) Analytical SEC results of 6His-MBP-Mis18α (orange), 6His-MBP-Mis18β (blue), 6His-MBP-Mis18α + 6His-MBP-Mis18β (green), and 6His-MBP-Mis18α + 6His-MBP-Mis18β + His-tagged TEV protease (His-TEVp) incubated at 4°C for 16 hr (red and purple). Experiments were done using the protein concentrations indicated in the figure with a SEC buffer containing 30 mM HEPES pH 7.5, 300 mM NaCl, and 1 mM TCEP. The elution volumes of thyroglobulin (670 kD), aldolase (158 kD), ovalbumin (44 kD), and myoglobin (17 kD) are shown as standards. Red vertical lines indicate fractions collected for Tricine--SDS-PAGE analyses. Gels were stained with CBB. (**B**) Analytical SEC results of repeated experiments in (**A**) using the SEC buffer from previous report ([@bib39]) containing 50 mM Tris-HCl pH 7.5, 350 mM NaCl, 2.5% glycerol, 0.05% NP-40, and 5 mM β-mercaptoethanol.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.013](10.7554/eLife.23352.013)

Trimers of C-terminal helices and dimers of Yippee domains mediate hexamer formation {#s2-8}
------------------------------------------------------------------------------------

To dissect the mechanism of Mis18 oligomerization, we generated a series of co-expression constructs of Mis18α:Mis18β variants and characterized the purified protein complexes using analytical SEC and sedimentation velocity AUC ([Figure 6A--C](#fig6){ref-type="fig"}). Both Mis18α^1-191^:Mis18β^1-189^ (N-terminal tail + Yippee domain) and Mis18α^78-191^:Mis18β^73-189^ (Yippee domain) form hetero-dimers ([Figure 6A--C](#fig6){ref-type="fig"}), in agreement with a recent report ([@bib56]). On the other hand, the three complexes encompassing the C-terminal helices of Mis18α and Mis18β (6His-Mis18α^192-233^-mCherry:MBP-Mis18β^190-229^, Mis18α^192-233^-mCherry:Mis18β^190-229^, 6His-Mis18α^192-233^:MBP-Mis18β^190-229^) had molecular masses consistent with the presence of two Mis18α and one Mis18β subunit ([Figure 6A--C](#fig6){ref-type="fig"}), indicating that this is the region of the complex that established the 2:1 ratio of the Mis18α and Mis18β subunits. When considering previous evidence that the Mis18α Yippee domain can also homo-dimerize ([@bib56]), we can now propose a schematic model for the Mis18α:Mis18β complex ([Figure 6F](#fig6){ref-type="fig"}) in which the trimeric C-terminal helices promote the assembly of three dimeric Yippee domain interfaces, two of which being α:β and one being α:α.

To identify the binding site for M18BP1^1-140^ on the Mis18α:Mis18β complex, we immobilized MBP-M18BP1^1-140^ on an amylose resin and used it as an affinity reagent to pull-down the Mis18α:Mis18β variants described previously in this section. We found that MBP-M18BP1^1-140^ bound the Mis18α:Mis18β Yippee domain dimer but not the C-terminal helices ([Figure 6D](#fig6){ref-type="fig"}). Binding was specific for the Mis18α:Mis18β heterodimeric arrangement of Yippee domains, because neither 6His-Mis18α^78-191^ nor 6His-Mis18β^73-189^ bound M18BP1^1-140^ in isolation ([Figure 6E](#fig6){ref-type="fig"}).

Mis18α:Mis18β-mediated dimerization of M18BP1 strengthens centromere association {#s2-9}
--------------------------------------------------------------------------------

We were able to reconstitute the core of the Mis18 complex by combining Mis18α:Mis18β with M18BP1^1--140^-MBP or M18BP1^1--228^-MBP. The purified complexes appeared monodisperse in SEC profiles ([Figure 7A](#fig7){ref-type="fig"}), and we obtained an estimate of their MW by sedimentation velocity AUC ([Figure 7B--C](#fig7){ref-type="fig"}). In line with the results in the previous section, Mis18α:Mis18β:M18BP1^1--140^-MBP and Mis18α:Mis18β:M18BP1^1--228^-MBP have the molecular masses expected for a single Mis18α:Mis18β hexamer plus two M18BP1^1--140^-MBP or M18BP1^1--228^-MBP moieties ([Figure 7C](#fig7){ref-type="fig"}). The distribution plots of the complexes showed single prominent peaks, suggesting that these samples contain a single predominant species ([Figure 7B](#fig7){ref-type="fig"}). We conclude that the core of the human Mis18 complex contains four Mis18α subunits, two Mis18β subunits, and binding sites for two M18BP1 N-terminal regions ([Figure 6F](#fig6){ref-type="fig"}).10.7554/eLife.23352.014Figure 7.Mis18α:Mis18β-hexamer mediates dimerization of M18BP1.(**A**) Analytical SEC results of M18BP1^1--140^-MBP (cyan), M18BP1^1--228^-MBP (red), Mis18α:Mis18β:M18BP1^1--140^-MBP (purple), Mis18α:Mis18β:M18BP1^1--228^-MBP (green). The elution volumes of thyroglobulin (670 kD), ferritin (440 kD), catalase (240 kD) and ovalbumin (44 kD) are shown as standards. Red lines indicate fractions collected for Tricine--SDS-PAGE analyses. Gels were stained with CBB. (**B**) Sedimentation velocity AUC results of the same samples used in the analytical SEC experiments (panel **A**). The best-fit size distributions are shown with the colors indicated in panel **A**. Data profiles used for curve-fitting analyses are shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. (**C**) Summary table of the results obtained from the AUC experiments of panel **B**. Sed. coef., sedimentation coefficient; MW~obs~., observed molecular weight; MW~theo~., theoretical molecular weight. (**D**) Western blot results of co-immunoprecipitation experiments using GFP-Trap_A beads. HeLa CENP-A-SNAP + EGFP-M18BP1^1--140^-P2A-T2A-mCherry-M18BP1^1--140^, EGFP-M18BP1^1--140/T40D/S110E^-P2A-T2A-mCherry-M18BP1^1--140/T40D/S110E^, GST-EGFP-M18BP1^1--140^-P2A-T2A-GST-mCherry-M18BP1^1--140^, or GST-EGFP-M18BP1^1--140/T40D/S110E^-P2A-T2A-GST-mCherry-M18BP1^1--140/T40D/S110E^ were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.014](10.7554/eLife.23352.014)10.7554/eLife.23352.015Figure 7---figure supplement 1.Data profiles for AUC experiments.Best-fitting results of the sedimentation velocity AUC data of M18BP1^1--140^-MBP, M18BP1^1--228^-MBP, Mis18α:Mis18β:M18BP1^1--140^-MBP, and Mis18α:Mis18β:M18BP1^1--228^-MBP. Residuals represent the deviation of the continuous *c*(*s*) distribution model from the observed signals. The values of RMSD for data fitting are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.015](10.7554/eLife.23352.015)

This binding model predicts that M18BP1 can form dimers in HeLa cells by forming a complex with Mis18α:Mis18β. To test this idea, we generated HeLa CENP-A-SNAP cell lines to co-express EGFP-M18BP1^1--140^ and mCherry-M18BP1^1--140^. As negative control, we co-expressed EGFP-M18BP1^1--140/T40D/S110E^ and mCherry-M18BP1^1--140/T40D/S110E^. We performed co-IP experiments with anti-GFP antibody conjugated beads using lysates from these HeLa cell lines previously treated with the CDK1 inhibitor RO-3306. EGFP-M18BP1^1--140^ co-immunoprecipitated with mCherry-M18BP1^1--140^ and Mis18β, while EGFP-M18BP1^1--140/T40D/S110E^ failed to co-immunoprecipitate with either, indicating that dimerization of M18BP1^1--140^ requires binding to Mis18α:Mis18β in HeLa cells ([Figure 7D](#fig7){ref-type="fig"}).

We asked if the role of the Mis18α:Mis18β complex as a trigger of M18BP1 dimerization could be rescued by fusing M18BP1 to GST, which is known to form homodimers ([@bib29]; [@bib32]). We therefore generated HeLa CENP-A-SNAP cell lines co-expressing GST-EGFP-M18BP1^1--140^ and GST-mCherry-M18BP1^1--140^, or GST-EGFP-M18BP1^1--140/T40D/S110E^ and GST-mCherry-M18BP1^1--140/T40D/S110E^. Co-IP experiments showed that GST did not interfere with the interaction of M18BP1^1--140^ with Mis18β ([Figure 7D](#fig7){ref-type="fig"}). As predicted, however, GST rescued the dimerization defect caused by phosphomimetic mutations that prevent the binding of M18BP1 to the Mis18α:Mis18β complex.

We hypothesized that a physiological meaning of the Mis18-mediated dimerization of M18BP1 is to strengthen the affinity of the Mis18α:Mis18β complex for centromeres. To test this hypothesis, we asked if forced dimerization with GST rescued the centromere localization defect of M18BP1 mutants rendering it incapable of binding the Mis18 complex. Toward this end, we generated HeLa CENP-A-SNAP cell lines expressing either GST-EGFP-M18BP1^1--1132^ or GST-EGFP-M18BP1^141--1132^ ([Figure 8](#fig8){ref-type="fig"}), which are expected to dimerize even without binding Mis18α:Mis18β. GST-EGFP-M18BP1^1--1132^ showed clear localization at centromeres and its expression rescued CENP-A-SNAP loading and Mis18α localization in cells depleted of endogenous M18BP1, indicating that the M18BP1 construct is functional ([Figure 8A and C--E](#fig8){ref-type="fig"}). GST-EGFP-M18BP1^141--1132^ partially rescued the centromere localization defect of EGFP-M18BP1^141--1132^, with a distribution of GST-EGFP-M18BP1^141--1132^ fluorescence at centromeres that appeared to be significantly stronger and more focused in comparison to that of EGFP-M18BP1^141--1132^ ([Figures 2D](#fig2){ref-type="fig"}, [8B and E](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). In cells depleted of endogenous M18BP1, GST-EGFP-M18BP1^141--1132^ failed to recruit mCherry-Mis18α to centromeres and did not rescue the defect of CENP-A loading, suggesting that in addition to promoting dimerization and an interaction with centromeres, a physical interaction of M18BP1 with Mis18α:Mis18β is required for CENP-A loading ([Figure 8B--E](#fig8){ref-type="fig"}).10.7554/eLife.23352.016Figure 8.Oligomerization of Mis18 complex promotes robust centromere localization.(**A**, **B**) Representative images showing the fluorescence of CENP-A-SNAP-SiR, mCherry-Mis18α and GST-EGFP-M18BP1 in the fixed HeLa cells treated as described in [Figure 2A](#fig2){ref-type="fig"}. Centromeres were visualized with CREST sera. Scale bars represent 10 µm. (**C**--**E**) Quantification of the fluorescence intensity of CENP-A-SNAP-SiR (panel **C**), mCherry-Mis18α (panel **D**), or EGFP-M18BP1 variants (panel **E**) on each centromere. The quantification was performed and is presented in the same way described in the legend of [Figure 2](#fig2){ref-type="fig"}. P-Values are indicated on the graph (Student's t test).**DOI:** [http://dx.doi.org/10.7554/eLife.23352.016](10.7554/eLife.23352.016)10.7554/eLife.23352.017Figure 8---figure supplement 1.GST-EGFP-M18BP1^141-1132^ localizes more specifically to centromeres than EGFP-M18BP1^141-1132^.Representative images showing EGFP-M18BP1 fluorescence and the immunofluorescence of CREST sera of indicated HeLa cell lines treated as described in [Figure 2A](#fig2){ref-type="fig"}. Scale bars represent 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.23352.017](10.7554/eLife.23352.017)

Discussion {#s3}
==========

The evolutionarily conserved Mis18 complex is an essential component of the machinery that loads new CENP-A onto centromeres, but the molecular basis of its assembly had remained unclear. Here, we have reported that the first 140 residues of M18BP1 contain binding motifs that are necessary and sufficient for a strong interaction with Mis18α:Mis18β in vitro. This result extends very recent work from two other groups, which, by performing ectopic localization experiments with LacO or tetO arrays, identified a Mis18α:Mis18β binding region in longer N-terminal fragments (1--383 or 1--375) of M18BP1 ([@bib41]; [@bib55]).

Previous studies suggested that CDK1 activity regulates CENP-A incorporation into centromeres ([@bib35]; [@bib52]) and that part of this regulation is through phosphorylation of M18BP1, which prevents complex formation with Mis18α:Mis18β ([@bib35]). However, in the absence of a molecular basis for the interaction of M18BP1 with Mis18α:Mis18β, the details of this regulation had remained unclear. We show that each of the two Mis18α:Mis18β binding regions of M18BP1^1--140^ (1-60 and 61--140) contains a highly conserved CDK-phosphorylation motif. Using a series of purified M18BP1 proteins with non-phosphorylatable and phosphomimetic mutations, we demonstrated that Thr40 and Ser110 are targets of the CDK1:Cyclin B complex. When introduced in full length M18BP1, the phosphomimetic mutations T40D and S110E reduced recruitment of M18BP1, prevented recruitment of Mis18α to centromeres, and interfered with new CENP-A deposition. These defects are very similar to the defects observed upon expression of EGFP-M18BP1^141--1132^ in cells depleted of endogenous M18BP1, and point to M18BP1^1--140^ as a controlled interaction module for complex formation with Mis18α:Mis18β.

We used biochemical reconstitution to gain further insights into the organization of the Mis18 complex. The single-peak elution profile from analytical SEC and the single-peak sedimentation-coefficient-distribution profile from AUC of the Mis18α:Mis18β:M18BP1^1--140^-MBP complex indicate that the reconstituted samples are stable and homogeneous. We used these samples to determine the stoichiometry of human Mis18α:Mis18β and of the Mis18 core complex by [@bib53] AUC. The Mis18α:Mis18β complex is a hexamer containing four Mis18α and two Mis18β subunits, and it binds two M18BP1^1-140^ subunits. The functional importance of oligomerization of Mis18α and Mis18β for CENP-A loading has been highlighted in two additional recent studies ([@bib39]; [@bib56]). The single fission yeast ortholog of Mis18 uses both the Yippee and the C-terminal coiled-coil domains to form homo tetramers ([@bib56]). Full-length human Mis18α and Mis18β, on the other hand, have been reported to oligomerize via their C-terminal coiled-coil domains to form 2:2 heterotetramer ([@bib39]). Our results are inconsistent with this recent report. [@bib39] derived the molecular mass of the Mis18α:Mis18β complex through the Siegel-Monty equation ([@bib51]) with estimates of the Stokes radius (from SEC experiments) and of the sedimentation coefficient (from glycerol-gradient ultracentrifugation experiments) derived from Western blot analysis of SDS-PAGE, an approach that we deem more error prone in comparison to our combined sedimentation velocity and sedimentation equilibrium AUC analyses. We show that recombinant Mis18α:Mis18β complexes produced in insect cells and *E coli* have essentially identical hydrodynamic properties in different buffers and concentrations. Thus, the hexamer is the prevalent form of the Mis18α:Mis18β complex.

Our biochemical assays show that the Yippee domains of Mis18α and Mis18β are both required for achieving a strong interaction with M18BP1^1-140^. This suggests that the stoichiometry of Mis18β in the Mis18 complex limits the number of bound M18BP1, because two Mis18α:Mis18β Yippee domain hetero-dimers can be formed in one hexamer, and each can bind a copy of M18BP1^1-140^. Our results are consistent with evidence that M18BP1 interacts with the Mis18α:Mis18β complex only when both Mis18α and Mis18β subunits are co-expressed in a yeast-three-hybrid assay ([@bib19]). The 4:2:2 stoichiometry of the Mis18 complex likely provides a base to understand the assembly of the CENP-A loading machinery, and further structural analysis will have to examine the details of this unique octameric complex.

Overexpression of EGFP-M18BP1^1--140^ in HeLa cells had a strong dominant-negative effect on centromere localization of Mis18α:Mis18β and on CENP-A loading, suggesting that EGFP-M18BP1^1--140^ binds to Mis18α:Mis18β in HeLa cells and prevents its interaction with endogenous M18BP1. This result also indicates that the complex of EGFP-M18BP1^1--140^ with Mis18α:Mis18β cannot localize to centromeres. Indeed, we observed that M18BP1^141--1132^, which is unable to bind with Mis18α:Mis18β, localized to centromeres, although weakly, arguing that M18BP1^141--1132^ contains interaction modules for autonomous localization to centromeres. Mouse M18BP1 and frog M18BP1 isoforms were shown to interact with the CCAN protein CENP-C ([@bib5]; [@bib37]) through a binding domain located between the SANTA and SANT domains ([@bib5]; [@bib55]). We demonstrated that forced dimerization of M18BP1^141-1132^ using GST-tag increased its localization to centromeres in HeLa cells, supporting the hypothesis that Mis18α:Mis18β-mediated dimerization of M18BP1 is required to strengthen the interaction between the Mis18 complex and centromeric recruiters. However, GST-mediated dimerization did not rescue centromeric localization of EGFP-M18BP1^141--1132^ to the levels of full length EGFP-M18BP1, indicating that the interaction with Mis18α:Mis18β contributes to the localization mechanism even beyond dimerization. A physical interaction of Mis18β with the CENP-C C-terminal region might account for increased binding affinity ([@bib55]).

Combining our findings with those of recent studies ([@bib39]; [@bib41]; [@bib55]; [@bib56]), we conclude that full assembly of the Mis18 complex is important for its function. Our analysis demonstrates that the phosphorylation of Thr40 and Ser110 of M18BP1 by CDK1 prevents assembly of the Mis18 complex, thus describing a crucial mechanism to temporally restrict CENP-A loading to early G1 phase, when the levels of Cyclin B rapidly decline after their mitotic peak. In conclusion, the available evidence depicts a complex binding mechanism for the centromere localization of the Mis18 complex, with multiple binding interfaces and a complex regulation by mitotic kinases. Here, we have dissected the regulation of a crucial element of this interface.

Materials and methods {#s4}
=====================

Plasmids {#s4-1}
--------

Plasmid pETDuet-8His was generated from pETDuet-1 (Novagen) by adding the coding DNA sequence (CDS) of 8His-tag immediately after the *Xho*I site using an modified inverse PCR method ([@bib14]). Plasmid pETDuet-MBP-8His was generated by inserting the CDS of MBP (*E. coli* malE Lys27--Lys396) followed by a tobacco etch virus (TEV) protease cleavage-site between *Nco*I and *Xho*I sites of pETDuet-8His. Restriction sites of *Bgl*II and *Nco*I in the CDS of MBP were removed and two mutations (A312V/I317V) ([@bib60]) were introduced into MBP with a site-directed mutagenesis PCR method ([@bib46]). Codon-optimized cDNA of human M18BP1 was purchased from GeneArt. The CDSs of M18BP1 fragments were subcloned into pETDuet-MBP-8His plasmid between TEV-protease cleavage site and 8His-tag using *Bam*HI and *Xho*I sites to generate pETDuet-MBP-M18BP1-8His plasmids. Plasmid pGEX6PT-M18BP1^1--1132^-MBP was generated by inserting the CDS of a TEV-protease cleavage site followed by M18BP1 and MBP (modified sequence described above) between *Bam*HI and *Not*I sites of pGEX-6P-1 (GE Healthcare). The original *Bam*HI site of pGEX-6P-1 was removed by ligation with *Bgl*II site while a new *Bam*HI site was introduced after the TEV-protease cleavage site. A *Xho*I site was introduced between M18BP1 and MBP to enable subcloning of M18BP1 fragments using *Bam*HI and *Xho*I sites. Mutations were introduced using the PCR method ([@bib46]).

Codon-optimized cDNAs of human Mis18α and Mis18β were purchased from GeneArt. Plasmid pLIB-6His-Mis18α (or Mis18β) was generated by inserting the CDS of 6His-tag followed by a TEV-protease cleavage site and Mis18α (or Mis18β) between *Bam*HI and *Sal*I sites of pLIB ([@bib62]). Plasmid pLIB-MBP-Mis18α (or Mis18β) was generated by inserting the CDS of MBP followed by a TEV-protease cleavage site and Mis18α (or Mis18β) between *Bam*HI and *Sal*I sites of pLIB. In these constructs, the original *Bam*HI site of pLIB was abolished by ligation with *Bgl*II site while a new *Bam*HI site was introduced after the TEV-protease cleavage site. Plasmid pLIB-Mis18β was generated by inserting the CDS of Mis18β between *Bam*HI and *Sal*I sites of pLIB. Co-expression plasmids for baculovirus expression (pBIG1e-6His-Mis18α:Mis18β, pBIG1e-6His-Mis18α:MBP-Mis18β, pBIG1e-6His-Mis18β:MBP-Mis18α) were generated by ligating the DNA fragments of two expression cassettes amplified from pLIB plasmids described above with the pBIG1e backbone ([@bib62]). *E. coli* co-expression plasmids of pETDuet-6His-Mis18α-MBP-Mis18β variants were generated by inserting the CDS of Mis18α (or its variants) followed by a ribosome-binding site, the CDSs of MBP and Mis18β (or its variants) between *Bam*HI and *Xho*I sites of pETDuet-1. TEV-protease cleavage sites were introduced both between 6His and Mis18α and between MBP and Mis18β for removal of 6His-tag and MBP-tag during protein purification. Plasmid pETDuet-6His-Mis18α^192-233^-mCherry-MBP-Mis18β^190-229^ was generated by inserting the CDS of mCherry into the plasmid pETDuet-6His-Mis18α^192-233^-MBP-Mis18β^190-229^ at the C-terminal side of Mis18α^192--233^. Plasmids pETDuet-6His-Mis18α^78-191^ and pETDuet-6His-Mis18β^73-189^ were generated by inserting the CDS of a TEV-protease cleavage site followed by the CDS of Mis18α^78--191^or Mis18β^73--189^ between *Bam*HI and *Xho*I sites of pETDuet-1. plasmids pETDuet-6His-MBP-Mis18α and pETDuet-6His-MBP-Mis18β were generated by inserting the CDS of MBP followed by a TEV-protease cleavage site and Mis18α or Mis18β between *Bam*HI and *Xho*I sites of pETDuet-1.

Codon-optimized cDNAs of human CDK1 and Cyclin B1 were obtained from GeneArt. The CDSs of CDK1 and Cyclin B1 were individually subcloned in pLIB with N-terminal GST- and 6His-tag, respectively. They were then subcloned in pBIG1a to generate pBIG1a -GST-CDK1:6His-Cyclin-B1.

Plasmid pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 was generated by inserting the CDS of EGFP-NLS-P2AT2A-mCherry-PTS1 between *Bam*HI and *Bcl*I of pcDNA5/FRT/TO (Thermo Fisher Scientific). The original *Bam*HI site of pcDNA5/FRT/TO was removed by ligation with *Bgl*II site, while a new *Bam*HI site was introduced after the CDS of EGFP. The CDS of NLS can be replaced with the CDS of a protein of interest using *Bam*HI and *Xho*I sites. The CDS of peroxisomal targeting signal--1 (PTS1) can be replaced with the CDS of a protein of interest using *Nhe*I and *Xma*I sites. Plasmid pcDNA5-MTS-TagBFP-EGFP-NLS-P2AT2A-mCherry-PTS1 was generated by inserting the CDS of mitochondrial targeting signal (MTS) fused TagBFP (Evrogen) (MTS-TagBFP) followed by P2AT2A to the upstream of the EGFP of pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1.

Plasmids pcDNA5-EGFP-M18BP1-P2AT2A-mCherry-Mis18α variants were generated by replacing the CDSs of NLS and PTS1 of pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 with these of M18BP1 variants and Mis18α, respectively, using the restriction sites described above. No stop codon was placed between the CDSs of M18BP1 and P2AT2A. Plasmids pcDNA5-GST-EGFP-M18BP1(1-1132)-P2AT2A-mCherry-Mis18α and pcDNA5-GST-EGFP-M18BP1(141-1132)-P2AT2A-mCherry-Mis18α were generated by inserting the CDS of GST between *Hind*III and *Kpn*I sites of pcDNA5-EGFP-M18BP1(1--1132)-P2AT2A-mCherry-Mis18α and pcDNA5-EGFP-M18BP1(141-1132)-P2AT2A-mCherry-Mis18α. Plasmids pcDNA5-EGFP-M18BP1(1-140)-P2AT2A-mCherry-M18BP1(1-140) and pcDNA5-EGFP-M18BP1(1-140/T40D/S110E)-P2AT2A-mCherry-M18BP1(1-140/T40D/S110E) were generated by replacing the CDS of Mis18α with the CDS of M18BP1(1--140) or M18BP1(1--140/T40D/S110E).

Plasmid pETDuet-CENP-A-SNAP-HA-PGK-NeoR was generated by ligating four DNA fragments (1 kb CENP-A gene sequence upstream form the stop codon, the CDS of SNAP-3HA, PGK promoter with neomycin resistant gene (NeoR), 1 kb CENP-A gene sequence downstream form the stop codon) and pETDuet backbone treated with *Xba*I and *Xho*I restriction enzymes using Gibson cloning method ([@bib21]). The CDS of SNAP-3HA was amplified from the pSS26m plasmid containing the CDS of CENP-A-SNAP-3HA, which was a gift from L.E.T. Jansen (Instituto Gulbenkian de Ciência, Portugal) ([@bib28]).

Plasmid pX330-CENP-A-sgRNA was generated by inserting annealed oligos (5'--CACCGCGAGTCCCTCCTCAAGGCCC--3', 5'--AAACGGGCCTTGAGGAGGGACTCGC--3') into *Bbs*I sites of pX330 ([@bib44]), which was purchased from Addgene.

All constructs were verified by DNA sequencing before being used for protein expression or as the templates for PCR. The list of all plasmids used in this study is presented in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}.

Protein expression {#s4-2}
------------------

*E. coli* cells of BL21-CodonPlus(DE3)-RIL strain transformed with expression plasmids were cultured in 2xYT media (16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) supplemented with ampicillin and chloramphenicol at 37°C. Protein expression was induced by adding IPTG to the final concentration of 0.2 mM when OD~600~ of the culture reached 0.6 and further incubation at 20°C for 16 hr.

Plasmids of pBIG1 derivatives carrying expression cassettes were recombined to baculoviral genome by Tn7 transposition in *E. coli* DH10EMBacY cells ([@bib59]). Recombined EMBacY with expression cassettes were extracted from bacteria cells and used to transfect Sf9 cells for baculovirus generation. Initial viruses were obtained after 3 days incubation of EMBacY and Sf9 cells with FuGENE reagent (Promega). Viruses were amplified using Sf9 cells. Litter-scale protein expression was performed by incubation of viruses and Tnao38 cells at 27°C for 4 days with starting density of 1.2 million Tnao38 cells per mL of Sf-900 III SFM media (Thermo Fisher Scientific).

Protein purification {#s4-3}
--------------------

All purification procedures were performed either on ice or at 4°C. C-terminal MBP-tagged M18BP1 protein samples were purified from *E. coli* cells expressing GST-M18BP1-MBP variants. The cells were suspended in buffer containing 50 mM HEPES pH 7.5, 500 mM NaCl, 1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and 1 mM PMSF and lysed by sonication. The clear supernatant obtained after centrifugation was incubated with glutathione sepharose resin (GE Healthcare) for \~16 hr. Protein-bound resin was washed with 100 column volumes of buffer A and incubated for \~16 hr with His-tagged TEV protease (His-TEVp) for on-resin cleavage at a stoichiometry of 1/10 with respect to the expected yield of the GST-M18BP1-MBP variant. His-TEVp cut between GST and M18BP1. Eluted M18BP1-MBP variant was separated using Ni resin (cOmplete His-tag purification resin, Roche) from His-TEVp and concentrated to more than 5 mg/ml.

N-terminal MBP-tagged M18BP1 protein samples were purified from *E. coli* cells expressing MBP-M18BP1-8His variants. The cells were suspended in buffer HST300 (30 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP) containing 1 mM PMSF and 10 mM imidazole and lysed by sonication. The clear supernatant obtained after centrifugation was incubated with Ni resin (Roche) for \~16 hr. Protein-bound resin was washed with 100 column volumes of buffer HST300 containing 10 mM imidazole. MBP-M18BP1-8His variants were eluted with 10 column volumes of buffer HST300 containing 400 mM imidazole and concentrated in buffer HST300 to more than 5 mg/ml. The concentration of imidazole were reduced to less than 10 mM by repetition twice of dilution of the concentrated protein sample with 10 times buffer HST300. MBP-8His was purified in the same way as MBP-M18BP1-8His.

Insect-cell-expressed Mis18α:Mis18β complex was purified from Tnao38 cells co-expressing 6His-tagged Mis18α and untagged Mis18β. The cells were suspended in buffer HST300 containing 10 mM imidazole and subjected to Ni-affinity purification using the same procedure as for purification of MBP-M18BP1-8His. Concentrated 6His-Mis18α:Mis18β complex was incubated with His-TEVp for \~16 hr to cleave off the His-tag. Mis18α:Mis18β complex was further purified using Superdex 200 10/300 GL SEC column (GE Healthcare) and concentrated to 5 mg/mL in buffer HST300. *E. coli*-expressed Mis18α:Mis18β variants were purified using the same procedure as for purification of insect-cell-expressed Mis18α:Mis18β complex. MBP-Mis18α:6His-Mis18β and 6His-Mis18α:MBP-Mis18β complexes were also purified from Tnao38 cells using the same procedure as for purification of Mis18α:Mis18β complex without the step of tag-cleavage using His-TEVp.

Purified Mis18α:Mis18β complex (insect cell expression) was incubated with 1.5--2 times of (molar ratio) M18BP1^1--140^-MBP or M18BP1^1--228^-MBP in buffer HST300. The Mis18α:Mis18β:M18BP1^N-terminus^MBP complexes were separated from excess M18BP1^1--140^-MBP or M18BP1^1--228^-MBP using SEC with Superdex 200 10/300 GL SEC column equilibrated in buffer HST300.

GST-CDK1:6His-Cyclin B1 was purified from Tnao38 cells using glutathione Sepharose (GE Healthcare) followed by size exclusion chromatography using HiLoad 16/60 Superdex 200 pg column (GE Healthcare) equilibrated in buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl, 1 mM TCEP, and 5% glycerol.

Phosphorylation using CDK1:Cyclin B1 {#s4-4}
------------------------------------

Purified MBP-M18BP1-8His variants and MBP-8His were incubated at the concentration of 10 μM with 50 nM GST-CDK1:6His-Cyclin B1 complex in the reaction solution containing 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP, 5 mM ATP, and 10 mM MgCl~2~ at 30°C for 2 hr.

Pull down assays using amylose resin {#s4-5}
------------------------------------

Proteins were diluted to 3 μM in 40 μL buffer HST300, unless otherwise noted, and mixed with 20 μL amylose resin (NEB) equilibrated with buffer HST300 or buffer with reduced NaCl concentration of 100 mM. One-third of this mixture was taken as input fraction and the rest two-thirds were incubated at 4°C for 30 min. Amylose-bound proteins were separated from unbound fraction by spinning down the amylose resin and washing with 500 μL buffer HST300 four times. The input and bound fractions were analyzed by Tricine--SDS-PAGE using normal gels and Phos-tag gels. The gels were stained with Coomassie brilliant blue (CBB). Phos-tag acrylamide gels containing 50 μM Phos-tag AAL-107 (NARD institute) were prepared according to the manufacture's protocol and were used to detect the mobility shift caused by phosphorylation.

Generation of HeLa cell lines {#s4-6}
-----------------------------

A HeLa CENP-A-SNAP cell line was directly generated from a Flp-In T-REx HeLa cell line generated by Stephen Taylor and colleagues ([@bib58]), which we did not further authenticate. All cell lines are described in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. We tagged the C-terminus of endogenous CENP-A loci with a SNAP-3HA-tag using CRISPR/Cas9-mediated genome engineering following the protocol previously described ([@bib44]) with modifications. The Flp-In T-REx HeLa cells were transfected with pX330-CENP-A-sgRNA together with the PCR-amplified rescue DNA fragment from pETDuet-CENP-A-SNAP-HA-PGK-NeoR that contained the CDS of SNAP-3HA-PGK-NeoR with 1 kb CENP-A genomic DNA flanking both sides. The positive clones were selected using G418, and the correct tagging was verified by confirming the centromere labeling of the early G1 cells with SNAP-Cell 647-SiR (NEB).

HeLa CENP-A-SNAP cell lines co-expressing EGFP-M18BP1 variants and mCherry-Mis18α were generated by transfecting the HeLa CENP-A-SNAP cells with pcDNA5-EGFP-M18BP1-P2AT2A-mCherry-Mis18α plasmids and pOG44 plasmid according to the protocol previously described ([@bib57], [@bib58]). HeLa cell lines co-expressing EGFP-NLS and mCherry-PTS1 with or without MTS-TagBFP were generated by transfecting the Flp-In T-REx HeLa cells with the pcDNA5-EGFP-NLS-P2AT2A-mCherry-PTS1 derived plasmids using the same protocol described above. Cell lines were regularly tested for mycoplasma contamination and tests found negative.

CENP-A loading experiment {#s4-7}
-------------------------

HeLa cells were placed in wells of 12-well plates in DMEM (PAN Biotech) supplemented with 10% tetracycline-free FBS (Thermo Fisher Scientific, Waltham, MA) and 2 mM l-glutamine (PAN-Biotech) and grown at 37°C in the presence of 5% CO~2~ for 24 hr. Then, the cells were treated with Lipofectamine RNAiMAX, serum-free OptiMEM (Thermo Fisher Scientific), 10 nM M18BP1 siRNA (5'-GAAGUCUGGUGUUAGGAAAdTdT-3') ([@bib19]) for 48 hr according to the manufacture's protocol, and the control cells were treated with Lipofectamine RNAiMAX and serum-free OptiMEM without siRNA. Doxycycline (Sigma) was added to the culture at a concentration of 50 ng/ml to induce protein expression and was kept in the media until the fixation of cells. Thymidine (1 mM final concentration) was used to arrest cells at S/G1 transition phase. When cells were released from thymidine, existing CENP-A-SNAP proteins were blocked using SNAP-Cell Block (NEB) according to the manufacture's protocol. STLC (5 μM final concentration) was used to arrest cells in prometaphase. The cells arrested in prometaphase were separated from other cells by mitotic-shake-off, released from STLC by extensive wash with the media and placed in wells of 24-well plates containing poly-lysine coated coverslips. Three hours later, the cells in early G1 phase attached on the coverslips and were treated with SNAP-Cell 647-SiR (NEB) to label newly synthesized CENP-A-SNAP according to the manufacture's protocol. Cells were fixed with PBS/PHEM (Pipes, Hepes, EGTA, and MgCl~2~)-paraformaldehyde 4% followed by permeabilization with PBS/PHEM--Triton X-100 0.5% and immunostaining. The following antibodies were used for immunostaining: CREST/anticentromere antibodies (human autoimmune serum, Antibodies, Inc.), anti-M18BP1 (Bethyl A302-825A), anti-rabbit Rodamine red--conjugated, anti-human DyLight 405--conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. Coverslips were mounted with Mowiol mounting media (EMD Millipore) and imaged using a 60× oil immersion objective lens on a DeltaVision deconvolution microscope. Quantification of centromere signals were performed using the software Fiji with a script from a previous study ([@bib2]) with modifications for semi-automated processing. Briefly, average projections were made from z-stacks of recorded images. Centromere spots were chosen based on the parameters of shape, size, and intensity using the images obtained with CREST-staining, and their positions were recorded. The mean intensity value of adjacent pixels of a centromere spot was subtracted as background intensity from the mean intensity value of the centromere spot. Statistical analysis of the quantified intensity was performed and the plots were generated with the software Prism 7 (GraphPad Software Inc.).

Co-immunoprecipitation experiment {#s4-8}
---------------------------------

HeLa cells were grown in DMEM supplemented with 10% tetracycline-free fetal bovine serum, 1% L-glutamine and 1% Penicillin-Streptomycin at 37°C in a 5% CO~2~ atmosphere. Cells were treated with 50 ng/mL doxycycline (Sigma) for 18 hr and then treated with both 50 ng/mL doxycycline and 9 µM CDK1 inhibitor RO-3306 (Merck) for additional 6 hr before harvest. Cells were washed twice with PBS, resuspended in lysis buffer containing 75 mM HEPES pH 7.5, 1.5 mM EGTA, 1.5 mM MgCl~2~, 150 mM NaCl, 10% glycerol, 0.1% NP-40, 1 mM PMSF and Protease Inhibitor Mix HP Plus (SERVA), lysed using Bioruptor Plus sonication device (Diagenode) and centrifuged at 16,000 x g for 30 min at 4°C. The supernatant containing 2 mg protein was incubated with 7.5 µl GFP-Trap_A beads (Chromotek) for 2 hr at 4°C. The beads were washed thrice with the lysis buffer containing 300 mM NaCl instead of 150 mM NaCl. Proteins were eluted by adding SDS sample buffer and were analyzed using Tricine-SDS-PAGE and Western blot analysis. EGFP-M18BP1, mCherry-M18BP1, mCherry-Mis18α, Mis18β and vinculin were detected using following antibodies: anti-GFP (Abcam, AB6556), anti-mCherry (Novus, NBP1-96752), anti-Mis18β (Atlas, HPA052271), anti-vinculin (Sigma, V9131) anti-mouse-HRP (Amersham, NXA931-1ML) and anti-rabbit-HRP (Amersham, NXA934-1ML).

Analytical size-exclusion chromatography {#s4-9}
----------------------------------------

Size-exclusion chromatography (SEC) experiments were performed on calibrated Superose 6 increase 5/150 GL column or Superose 200 increase 5/150 GL column (GE Healthcare). Purified protein samples were applied to the column at 10 μM, unless otherwise noted, and eluted under isocratic condition at 4°C in buffer HST300 at a flow rate of 0.1 ml/min. Fractions were collected and analyzed by Tricine--SDS-PAGE and the gels were stained with CBB or SYPRO Ruby (Thermo Fisher Scientific).

Analytical ultracentrifugation {#s4-10}
------------------------------

Sedimentation velocity AUC was performed at 42,000 rpm at 20°C in a Beckman XL-A ultracentrifuge. Purified protein samples were diluted to 0.3--0.5 mg/mL in buffer HST300 and loaded into standard double-sector centerpieces. The cells were scanned at 280 nm every minute and 300 scans were recorded for every sample. Data were analyzed using the program SEDFIT ([@bib48]) with the model of continuous *c*(*s*) distribution. The partial specific volumes of the proteins, buffer density, and buffer viscosity were estimated using the program SEDNTERP. Data figures were generated using the program GUSSI.

Sedimentation equilibrium AUC was performed at 20°C using standard Epon six-channel centerpieces. Purified Mis18α:Mis18β complex was diluted to five different concentrations (6, 4, 2, 1, and 0.5 μM, assuming the MW of the complex is 154 kD) and centrifuged at 5000, 7000, and 10000 rpm until samples in the cells reached sedimentation equilibrium. Protein sedimentation was recorded at 280 and/or 230 nm. Data were processed using the program SEDFIT and analyzed using the program SEDPHAT ([www.analyticalultracentrifugation.com](http://www.analyticalultracentrifugation.com)).

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100000781European Research Council AdG 669686 RECEPIANCE to Andrea Musacchio.

-   http://dx.doi.org/10.13039/501100001659Deutsche Forschungsgemeinschaft Collaborative Research Centre (CRC) 1093 to Andrea Musacchio.

-   http://dx.doi.org/10.13039/100005156Alexander von Humboldt-Stiftung Postdoctoral fellowship to Dongqing Pan, Priyanka Singh.

We thank Lars ET Jansen for sharing reagents. We thank the members of the Musacchio laboratory, especially Stefano Maffini, Charlotte Smith, and Katharina Overlack for helpful advice and discussions. AM acknowledges funding by the European Union's seventh Framework Program ERC advanced grant agreement RECEPIANCE and the DFG's Collaborative Research Centre (CRC) 1093. DP and PS gratefully acknowledge support from the Alexander von Humboldt Foundation through Humboldt Research Fellowships.

Additional information {#s5}
======================

AM: Reviewing editor, *eLife*.

The other authors declare that no competing interests exist.

DP, Conception and design, Acquisition of data (generated constructs and purified proteins, performed pull-down assays and analytical SEC experiments, generated HeLa CENP-A-SNAP cell line, generated HeLa cell lines and performed CENP-A loading experiments, and performed AUC experiments), Analysis and interpretation of data, Drafting or revising the article.

KK, Acquisition of data (generated HeLa CENP-A-SNAP cell line, generated HeLa cell lines and performed CENP-A loading experiments), Analysis and interpretation of data.

AP, Acquisition of data (performed AUC experiments), Analysis and interpretation of data.

AT, Acquisition of data (generated HeLa cell lines and performed CENP-A loading experiments).

KW, Acquisition of data (generated HeLa cell lines, performed CENP-A loading experiments and performed co-IP experiments), Analysis and interpretation of data.

PS, Contributed unpublished essential data or reagents (generated constructs and purified proteins).

AR, Acquisition of data (generated HeLa CENP-A-SNAP cell line), Analysis and interpretation of data.

AWB, Analysis and interpretation of data (generated HeLa CENP-A-SNAP cell line).

AM, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

Additional files {#s6}
================

10.7554/eLife.23352.018

###### Plasmid vectors used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.23352.018](10.7554/eLife.23352.018)

10.7554/eLife.23352.019

###### HeLa cell lines used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.23352.019](10.7554/eLife.23352.019)

10.7554/eLife.23352.020

###### Fluorescence intensity data.

**DOI:** [http://dx.doi.org/10.7554/eLife.23352.020](10.7554/eLife.23352.020)

10.7554/eLife.23352.021

Decision letter

Akhtar

Asifa

Max Planck Institute for Immunobiology and Epigenetics

,

Germany

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"CDK-regulated oligomerization of M18BP1 on a Mis18 hexamer is necessary for CENP-A loading\" for consideration by *eLife*. Your article has been favorably evaluated by Jessica Tyler (Senior Editor) and three reviewers, one of whom, Asifa Akhtar, is a member of our Board of Reviewing Editors.

The reviewers appreciated that this manuscript presents a thorough biochemical characterization of the Mis18 heterohexamer and that specific M18BP1 phosphosites regulate Mis18α/β binding. Although these contributions are worthwhile, the fact that M18BP1 phosphorylation regulates Mis18α/β binding has been reported previously which impinges on the overall novelty of the manuscript. Moreover, since very different experimental protocols for reconstitutions are used between this and an earlier study, it remains possible that the complex may exist in different stoichiometry, this issue still remains open for discussion at this stage. Overall, the reviewers were of the opinion that the manuscript represents a modest advance in the field at this stage and discussed that the manuscript could perhaps be improved either by: (1) firmly establishing the biological role of the hexamer vs. a tetramer and by providing a better explanation for the difference between their results and the previous literature, or (2) from better delineating the role of the dimerization of M18BP1 via the Mis18 complex.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

Reviewer \#1:

Overall, this is a very thorough study showing the dependency of Mis18α/Mis18β localisation to the centromeres and the M18BP1 phosphorylation by CDK1/CycB. Their identification of the phosphorylation sites and corresponding mutations for those sites clearly indicates a functional relevance of this modification on M18BP1 and its interaction with Mis18α/Mis18β. Furthermore, they have validated their 2A-peptide dependent assay ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) carefully showing they have a robust and reliable method for their assays.

As they were addressing the minimally required fraction of the M18BP1 they discovered that 1-140aa was sufficient for the Mis18α/Mis18β interaction but this fraction of the protein was showing a dominant negative effect on the endogenous M18BP1 however there is not any assay showing that this could be by direct binding to the endogenous protein or not. Furthermore, the phoshomimics of the same fragment (1-140/T40D/S110E) did not show any dominant negative effect, which the authors explained by stating that the Mis18α/Mis18β interaction is lost. There could be a more convincing proof if the authors performed an IP or pulldown for these two aspects.

They claim that the dimerisation of M18BP1 strengthens Mis18α/b centromere localisation with the GST tagged M18BP1 ([Figure 6D-G](#fig6){ref-type="fig"}). This is done by comparing to the earlier assay ([Figure 2D](#fig2){ref-type="fig"}) however the fluorescence signal should not be quantified between the two independent cell lines unless they can be imaged side-by-side or no conclusion could be drawn from the signal becoming \"sharper\" (e.g. One explanation could be that the GST tag affects the stability of the proteins).

*Reviewer \#2:*

Centromeres are epigenetically specified by the H3 variant CENP-A. In this manuscript, Pan et al., report a series of elegant experiments that provide new insight into the process of CENP-A assembly focusing on the Mis18 complex a set of proteins essential for delivering new CENP-A to centromeres. The authors present a set of biochemical experiments defining the domain of M18BP1 that binds to the Mis18α and β subcomplexes. They show this interaction is blocked by Cdk mediated phosphorylation and phosophomemetic mutations cause a defect in CENP-A assembly in cells.

Purification of the Mis18α/β subcomplex shows a multimeric complex which the authors find to be a hexamere consisting of 4 α and 2 β molecules and that this complex can bind to 2 M18BP1 N terminal fragments.

While this study overlaps with recent work from e.g. the Foltz lab they provide interesting new insights particularly with regard to Cdk regulation which is valuable to the field.

There are however some specific issues regarding the interpretation of some of the data that need to be resolved:

1\) The title and text speak of oligomerization of M18BP1. I don´t see any evidence for this. The authors show that the Mis18α/β subcomplex can bind two molecules of an N-terminal M18BP1 fragment. This does not in itself indicate oligomerization which implies a multimerization (i.e. more than two). Using the term \"Mis18α/β-induced dimerization of M18BP1\" seems to me more appropriate.

2\) Subsection "M18BP1^1--140^ contains two sequential binding regions for Mis18α:Mis18β":

By identifying two consecutive fragments on M18BP1 that both retain the ability to interact with the Mis18α/β proteins does not necessarily define \"sequential binding regions\" or a \"bipartite\" (first paragraph) binding site exists as interpreted by the authors. Because the two fragments are adjacent to one another these results are consistent with a single continuous binding interface that is artificially broken into two, each retaining some binding activity. Calling this a bipartite binding site is misleading and should not be described as such.

3\) Mis18αβ stoichiometry:

This manuscript presents biophysical data on the stoichiometry of the Mis18α/β interpreted to be 4xalpha with 2x beta subunits. As indicated, this is inconsistent with a previous report. The authors explain this discrepancy by the fact that they co-express the α and β subunit while in the Nardi et al. study (Nardi et al., 2016), α and β are expressed and purified separately and then mixed in a 1:1 ratio.

While this is a possible explanation this does not mean the experiment by the authors is superior or more likely to be correct. Given that Mis18α and β can be expressed separately and able to form a complex indicates that the stoichiometry can be established dynamically from preexisting components and does not need to be established co-translationally.

Further, what is the relative expression level of Mis18α and β in the insect cells used by the authors? Can the skewed α/β ration be a consequence of relative over expression of Mis18α?

At least, the authors should leave open the possibility that the hexamer is one likely conformation but perhaps, depending on the context, other conformations may exist.

4\) [Figures 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}:

Why normalize to CREST signals? This is likely to create normalization artifacts as CREST signals appear to be rather poor with high background. Further, CREST stains a region that is broader than the CENP-A domain due to CENP-B staining further complicating normalization. Finally, and importantly, most CREST antibodies recognize, in part, CENP-A which means that the changes in CENP-A signal also potentially affect the normalization signal. CENP-A-SNAP values should simply be background corrected but not normalized.

5\) [Figures 2E-G](#fig2){ref-type="fig"}, [4C-E,](#fig4){ref-type="fig"} and [6E-G](#fig6){ref-type="fig"}:

Box plots are shown of centromere signal values. The spread in this data represents the biological variance in centromere intensities not the experimental variance. How often are these experiments repeated? In order to make any claim regarding differences and their significance (as in [Figure 6G](#fig6){ref-type="fig"}) it is meaningless to compare the variance in centromere intensities. When enough centromeres are sampled there will always be a significance difference. What matters is the variance in the experiment itself. i.e. are the means of replicate experiments significantly different? Without this, these quantifications are not informative.

6\) Final section:

The argument of oligomerization and its benefit to M18BP1 recruitment is weakly supported by data. Essentially, the only evidence in support of this is the slight increase in M18BP1 localization when it is forced to dimerize by fusion to GST in the absence of its ability to dimerize via Mis18 proteins (by deletion of the N-terminal 140aa).

This experiment is however, poorly controlled. First, as I outlined above the level of significance of the difference in the signal intensities cannot be determined by comparing the variance in centromeres across cells in a signal experiment. Instead, the reproducibility of the difference between experiments should be tested. Secondly, it is not clear from this experiment whether the perceived increase in M18BP1 centromere localization by GST dimerization compensates for the lack of dimerization via the Mis18 proteins. In other words, does GST play a role here that would otherwise be provided by the Mis18 proteins? One way to test this is to fuse GST to full length M18BP1 and test its effect on localization. In this case, if the authors´ hypothesis is correct, then M18BP1 dimerization via M18alpha and beta is functional and further dimerization via GST would have no further contribution.

*Reviewer \#3:*

Centromere identity is epigenetically specified by nucleosomes in which H3 has been substituted for the centromere-specific histone H3 variant CENP-A. Faithful, site-specific transmission of CENP-A chromatin from one generation to the next is essential for chromosome segregation and long-term genome stability. This process is carried out by the CENP-A specific chaperone HJURP which is targeted to the proper locus by the Mis18 complex (Mis18α, Mis18β, and M18BP1) immediately following mitosis during early G1. Cell cycle regulated assembly and centromere recruitment of the Mis18 complex is essential for centromere inheritance, and a major focus of recent work in the centromere field has been to understand the basis of this regulation.

Previous studies have shown that Cdk phosphorylation prevents premature recruitment of the Mis18 complex to centromeres during G2 and mitosis (Silva, et al. 2012). This was extended by the demonstration that Cdk phosphorylation of M18BP1 prevents recruitment of Mis18α/β to the N-terminal 383 amino acids of M18BP1 (McKinley and Cheeseman, 2014). In this manuscript, Pan, et al. show that of the residues mutated by McKinley and Cheeseman, two of them in particular, T40 and S110, inhibit the direct interaction of M18BP1 with Mis18α/β when phosphorylated.

M18BP1 must associate with Mis18α/β to target the complex to G1 centromeres thus it is important to understand how the complex is assembled. Previous work using size exclusion chromatography and glycerol gradient sedimentation led to the proposal that the Mis18 complex comprises a Mis18 heterotetramer (2α:2β) formed by their C-terminal coiled-coil domains bound to an unknown number of M18BP1 molecules (Nardi, et al. 2016). In this work, Pan, et al. use sedimentation velocity and equilibrium ultracentrifugation to determine that the Mis18 complex comprises a Mis18 heterohexamer (4α:2β), which in turn can bind 2 copies of the M18BP1 N-terminus. The authors argue that a Mis18 hexamer is the true stoichiometry because the methods used in the previous study are more error-prone. In addition, they suggest that the previous study may have obtained a 2:2 stoichiometry because they combined a 1:1 molar ratio of separately purified Mis18α and Mis18β rather than coexpressing them in eukaryotic cells.

The major scientific contributions in this manuscript are 1) the biochemical characterization of the Mis18 heterohexamer which clarifies previous studies and 2) the specific M18BP1 phosphosites that regulate Mis18α/β binding. Although these contributions are worthwhile and the biochemical studies are well done it is not clear whether this work warrants publication in *eLife* given the relatively modest advance in our understanding of Mis18 complex function in centromere formation.

1\) The reason for the discrepancy between the stoichiometry measured by Pan, et al. and Nardi, et al. remains unclear. By size exclusion, Nardi et al. also appear to observe a mono-dispersed species with a migration consistent with their calculated molecular weight. Pan, et al. argue based on their analyses that the Mis18 complex adopts an elongated conformation, leading to its earlier elution in size exclusion chromatography. Therefore, if anything I would expect a molecular weight calculation based on SEC elution of this complex to overestimate rather than underestimate its stoichiometry. In the absence of data supporting the idea that the stoichiometry of the complex is \'titratable,\' I also don\'t find the notion that Nardi et al. observed a tetramer simply because they mixed Mis18α and Mis18β in a 1:1 ratio compelling. If the ratio were off, presumably Nardi et al. would have seen a population at equilibrium containing some hexamer and some monomer/dimer/trimer. The difference in observed species may likely be due to the different expression systems used (bacterial vs. eukaryotic) and resulting differences in protein modifications/folding/etc., but there may also be some interesting biology in the differences. On the other hand, elaborating on the technical differences between the methods to clarify why the Siegel-Monty method is more error-prone would be helpful.

I don\'t think it\'s specifically up to the authors in this paper to resolve the reason for this discrepancy, but given that it\'s not clear whether we\'re looking at precisely the same complex as in Nardi et al. I think it\'s important for the authors to provide some additional characterization of the hexamer. Is the coiled-coil domain involved in hexamerization? Do the coiled-coil mutations described by Nardi et al. affect hexamer formation? Is the hexamer comprised of a Mis18α/β tetrameric core mediated by coiled coils with additional Mis18α bound by a different mechanism (e.g., the Yippee domain, which is also used for tetramerization in SpMis18)? The Musacchio lab has made extensive use of cross-linking/mass spectrometry in the past to understand the organization of multi-protein complexes -- perhaps this could shed light on differences between the Nardi and Pan Mis18 complexes.

2\) Although it\'s clear that Mis18 complex assembly is required for its recruitment, it is not clear whether the cell cycle timing of its recruitment is strictly determined by regulating the timing of complex assembly or whether regulation of some additional interaction plays a role. Silva, et al. found that mutating 24 putative Cdk sites (including S110 but not T40) in M18BP1 uncoupled its centromere localization from cell cycle regulation, allowing its recruitment in mitosis and G2. Can this be recapitulated by the lone S110A (or T40V/S110A) mutant characterized by Pan, et al.?

10.7554/eLife.23352.022

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

Reviewer \#1:

*\[...\] As they were addressing the minimally required fraction of the M18BP1 they discovered that 1-140aa was sufficient for the Mis18α/Mis18β interaction but this fraction of the protein was showing a dominant negative effect on the endogenous M18BP1 however there is not any assay showing that this could be by direct binding to the endogenous protein or not. Furthermore, the phoshomimics of the same fragment (1-140/T40D/S110E) did not show any dominant negative effect, which the authors explained by stating that the Mis18α/Mis18β interaction is lost. There could be a more convincing proof if the authors performed an IP or pulldown for these two aspects.*

We thank the reviewer for suggesting the IP experiments. We have now performed co-IP experiments using anti-GFP antibody coupled beads to pull-down either EGFP-M18BP1(1-140) or EGFP-M18BP(1-140/T40D/S110E)

from the HeLa cell lines treated with the CDK1 inhibitor RO-3306. The results, shown in [Figure 4F](#fig4){ref-type="fig"}, demonstrate that EGFP-M18BP(1-140) interacts with Mis18⟨:Mis18® but EGFP-M18BP1(1-140/T40D/S110E) doesn't.

*They claim that the dimerisation of M18BP1 strengthens Mis18α/b centromere localisation with the GST tagged M18BP1 ([Figure 6D-G](#fig6){ref-type="fig"}). This is done by comparing to the earlier assay ([Figure 2D](#fig2){ref-type="fig"}) however the fluorescence signal should not be quantified between the two independent cell lines unless they can be imaged side-by-side or no conclusion could be drawn from the signal becoming \"sharper\" (e.g. One explanation could be that the GST tag affects the stability of the proteins).*

We agree with the reviewer that it is difficult to compare the sharpness of the centromere spots and that the word "sharp" may not be appropriate. To address this issue, we added a supplementary figure ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}) where we present five representative images from EGFP-M18BP1(141-1132) and GST-EGFP-M18BP1(141-1132) cells side by side. This facilitates the comparison of the cellular distribution of EGFP-M18BP1(141-1132) and GST-EGFP-M18BP1(141-1132). These images clarify that GST-EGFP-M18BP1(141-1132) localizes more specifically to centromeres than EGFP-M18BP1(141-1132). We also define this localization as "more specific" instead of "sharper" in the main text.

Reviewer \#2:

*\[...\] There are however some specific issues regarding the interpretation of some of the data that need to be resolved:*

*1) The title and text speak of oligomerization of M18BP1. I don´t see any evidence for this. The authors show that the Mis18α/β subcomplex can bind two molecules of an N-terminal M18BP1 fragment. This does not in itself indicate oligomerization which implies a multimerization (i.e. more than two). Using the term \"Mis18α/β-induced dimerization of M18BP1\" seems to me more appropriate.*

We agree with the reviewer that using the word "dimerization" is more accurate and we have changed the title accordingly.

2\) Subsection "M18BP11--140 contains two sequential binding regions for Mis18α:Mis18β":

*By identifying two consecutive fragments on M18BP1 that both retain the ability to interact with the Mis18α/β proteins does not necessarily define \"sequential binding regions\" or a \"bipartite\" (first paragraph) binding site exists as interpreted by the authors. Because the two fragments are adjacent to one another these results are consistent with a single continuous binding interface that is artificially broken into two, each retaining some binding activity. Calling this a bipartite binding site is misleading and should not be described as such.*

We have removed reference to a bipartite binding site and we only describe the binding data without trying to frame them in a precise definition.

*3) Mis18αβ stoichiometry:*

*This manuscript presents biophysical data on the stoichiometry of the Mis18α/β interpreted to be 4xalpha with 2xbeta subunits. As indicated, this is inconsistent with a previous report. The authors explain this discrepancy by the fact that they co-express the α and β subunit while in the Nardi et al. study (Nardi et al., 2016), α and β are expressed and purified separately and then mixed in a 1:1 ratio.*

*While this is a possible explanation this does not mean the experiment by the authors is superior or more likely to be correct. Given that Mis18α and β can be expressed separately and able to form a complex indicates that the stoichiometry can be established dynamically from preexisting components and does not need to be established co-translationally.*

*Further, what is the relative expression level of Mis18α and β in the insect cells used by the authors? Can the skewed α/β ration be a consequence of relative over expression of Mis18α?*

*At least, the authors should leave open the possibility that the hexamer is one likely conformation but perhaps, depending on the context, other conformations may exist.*

In this revised version of our manuscript, we have significantly extended our analysis of the subunit stoichiometry of the Mis18 complex. On the basis of this analysis, we conclude that the Mis18⟨:Mis18® does not take the form of a tetramer under any of the new conditions we have investigated, including conditions that recapitulate the previous experiments of Nardi and colleagues cited by the reviewer.

Specifically:

A\) Our original studies were carried out with protein purified from insect cells after co-expression of the ⟨ and ® subunits. We now report expression of isolated 6His-Mis18⟨ and 6His-Mis18® in *E. coli* cells. Both subunits were expressed but insoluble. However, we were able to purify Mis18⟨ and Mis18® in *E. coli* by co-expression, or through addition of 6His-MBP tags to increase their solubility. Removing the 6His-MBP tag before mixing 6His-MBP-Mis18⟨ and 6His-MBP-Mis18® caused both proteins to precipitate, but if the tags were removed after mixing, the complex remained soluble. We show that *E. coli*-expressed Mis18⟨:Mis18® complex, whether produced by co-expression or by mixing of individual subunits, has essentially the same hydrodynamic profile of the insect cell sample (by gel filtration and AUC), corresponding to a hexamer. These new analyses provide rather incontrovertible evidence that the dominant form of the Mis18⟨:Mis18® complex is the hexamer and that there are no other known conditions in which a tetramer might appear.

B\) We have now characterized the mechanism of hexamer formation. In agreement with Subramanian et al., 2016, the Mis18⟨:Mis18® Yippee domain form hetero-dimers and the Mis18⟨ Yippee domain also form homo-dimers. In addition, we show by AUC experiments that the Mis18⟨:Mis18® C-terminal helices form trimers containing one ® and two ⟨ subunits. These results strongly argue against the mechanism proposed by Nardi et al. that Mis18⟨ and Mis18® form tetramer via the interaction of their C-terminal helices. These experiments, shown in [Figure 6](#fig6){ref-type="fig"}, now allow us to propose a detailed model of the hexamer.

C\) In addition, we now show the Mis18⟨:Mis18® Yippee domain heterodimer is where M18BP1 binds, explaining the 4:2:2 stoichiometry.

D\) We kindly object to the statement that determining mass through sedimentation equilibrium and velocity "does not mean...superior or more likely to be correct". To our knowledge, sedimentation equilibrium is superior to any other technique for mass determination, as it is completely independent of macromolecular shape and does not rely on any form of calibration, a step that is of course highly likely to introduce artifacts, in particular if performed with a sample as heterogeneous as the one used by Nardi and colleagues. On this particular point, the reviewer is referred to our answer to reviewer 3, where we provide additional evidence that the technical quality of the experiments by Nardi et al. is not comparable to that presented here.

*4) [Figure 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}:*

*Why normalize to CREST signals? This is likely to create normalization artifacts as CREST signals appear to be rather poor with high background. Further, CREST stains a region that is broader than the CENP-A domain due to CENP-B staining further complicating normalization. Finally, and importantly, most CREST antibodies recognize, in part, CENP-A which means that the changes in CENP-A signal also potentially affect the normalization signal. CENP-A-SNAP values should simply be background corrected but not normalized.*

We agree with the reviewer that the CREST signal in the blue channel is rather poor and shows high background. This is mainly due to the anti-human DyLight 405-conjugated secondary antibody we used. We also take the point that the normalization strategy we had used was not ideal. We now use the CREST signal only to determine the position of centromeres, and quantified all the images again without normalization against CREST. All images in this revised version have been re-quantified. Importantly, the new quantification does not change any of our original conclusions.

*5) [Figures 2E-G](#fig2){ref-type="fig"}, [4C-E](#fig4){ref-type="fig"}, and [6E--G](#fig6){ref-type="fig"}:*

*Box plots are shown of centromere signal values. The spread in this data represents the biological variance in centromere intensities not the experimental variance. How often are these experiments repeated? In order to make any claim regarding differences and their significance (as in [Figure 6G](#fig6){ref-type="fig"}) it is meaningless to compare the variance in centromere intensities. When enough centromeres are sampled there will always be a significance difference. What matters is the variance in the experiment itself. i.e. are the means of replicate experiments significantly different? Without this, these quantifications are not informative.*

We thank the reviewer for this important suggestion. We have carried out three independent replicas of the CENP-A loading experiments. In our original quantification, we treated images from independent replicas as part of the same dataset. To address the reviewer's concern, we have re-quantified each replica separately, and the new graphs present the mean values from three independent experiments. For each replica, a mean value of fluorescence intensity was obtained from \>100 centromere spots from 10-12 early G1 cells. Error bars indicate SEM. Student's t tests were performed using the new quantifications.

*6) Final section:*

*The argument of oligomerization and its benefit to M18BP1 recruitment is weakly supported by data. Essentially, the only evidence in support of this is the slight increase in M18BP1 localization when it is forced to dimerize by fusion to GST in the absence of its ability to dimerize via Mis18 proteins (by deletion of the N-terminal 140aa).*

*This experiment is however, poorly controlled. First, as I outlined above the level of significance of the difference in the signal intensities cannot be determined by comparing the variance in centromeres across cells in a signal experiment. Instead, the reproducibility of the difference between experiments should be tested. Secondly, it is not clear from this experiment whether the perceived increase in M18BP1 centromere localization by GST dimerization compensates for the lack of dimerization via the Mis18 proteins. In other words, does GST play a role here that would otherwise be provided by the Mis18 proteins? One way to test this is to fuse GST to full length M18BP1 and test its effect on localization. In this case, if the authors´ hypothesis is correct, then M18BP1 dimerization via M18alpha and beta is functional and further dimerization via GST would have no further contribution.*

We thank the reviewer for making this important point. We agree that our experiment should include a control using GST-EGFP-M18BP1(1-1132), and we have made a HeLa CENP-A-SNAP cell line +GST-EGFP-M18BP1(1-1132)-P2AT2A-mCherry-Mis18α and performed CENP-A loading experiment as we did for other cell lines. GST-EGFP-M18BP1(1-1132) showed centromere localization as EGFP-M18BP1(1-1132) and was similarly able to rescue CENP-A loading and Mis18α localization under the depletion of endogenous M18BP1. Representative images and the quantification of the fluorescence intensity at centromeres are presented in [Figure 8](#fig8){ref-type="fig"}.

As described above in the response to the reviewer's major point 5, we have re-quantified the localization data and applied Student's t test again using the mean values from three independent experiments. This indicated a significant difference (P=0.0016,\*\*) of the centromere EGFP-fluorescence intensity between cell lines expressing GST-EGFP-M18BP1(141-1132) and EGFP-M18BP1(141-1132), which is presented in [Figure 8E](#fig8){ref-type="fig"}. Additionally, we included a supplementary figure (Figure ---figure supplement 1) to present five representative images from both EGFP-M18BP1(141-1132) and GST-EGFP-M18BP1(141-1132) cells side by side, which makes the more robust centromere localization of GST-EGFP-M18BP1(141-1132) in comparison to EGFP-M18BP1(141-1132) easier to grasp.

We also generated four additional HeLa cell lines co-expressing following tagged proteins:

1\. EGFP-M18BP1(1-140) and mCherry-M18BP1(1-140)

2\. EGFP-M18BP1(1-140/T40D/S110E) and mCherry-M18BP1(1-140/T40D/S110E)

3\. GST-EGFP-M18BP1(1-140) and GST-mCherry-M18BP1(1-140)

4\. GST-EGFP-M18BP1(1-140/T40D/S110E) and GST-mCherry-M18BP1(1-140/T40D/S110E)

These cells were treated with CDK1 inhibitor RO-3306 and lysed for co-IP experiments using anti-GFP antibody coupled beads. With these co-IP experiments, we showed that EGFP-M18BP1(1-140) only interacts with mCherry-M18BP1(1-140) when they can bind Mis18beta, supporting our model of M18BP1 dimerization via Mis18αlhpa:β complex. We also show that GST-EGFP-M18BP1(1-140/T40D/S110E) interacts with GST-mcherry-M18BP1(1-140/T40D/S110E) even it could not bind Mis18beta, confirming the dimerization of GST-tag in HeLa cells. These new results are shown in [Figure 7D](#fig7){ref-type="fig"}.

*Reviewer \#3:*

*Centromere identity is epigenetically specified by nucleosomes in which H3 has been substituted for the centromere-specific histone H3 variant CENP-A. Faithful, site-specific transmission of CENP-A chromatin from one generation to the next is essential for chromosome segregation and long-term genome stability. This process is carried out by the CENP-A specific chaperone HJURP which is targeted to the proper locus by the Mis18 complex (Mis18α, Mis18β, and M18BP1) immediately following mitosis during early G1. Cell cycle regulated assembly and centromere recruitment of the Mis18 complex is essential for centromere inheritance, and a major focus of recent work in the centromere field has been to understand the basis of this regulation.*

*Previous studies have shown that Cdk phosphorylation prevents premature recruitment of the Mis18 complex to centromeres during G2 and mitosis (Silva, et al. 2012). This was extended by the demonstration that Cdk phosphorylation of M18BP1 prevents recruitment of Mis18α/β to the N-terminal 383 amino acids of M18BP1 (McKinley and Cheeseman, 2014). In this manuscript, Pan, et al. show that of the residues mutated by McKinley and Cheeseman, two of them in particular, T40 and S110, inhibit the direct interaction of M18BP1 with Mis18α/β when phosphorylated.*

We thank the reviewer for these comments. While we appreciate the importance of previous work in this area, we would also like to point out that the paper of McKinley and Cheeseman (2014) studied a construct comprising residues 1-490 of M18BP1, and that these authors mutated 18 possible phosphorylation sites to Ala (M18BP1-CDK-A), without characterizing their function in detail, as it is natural given the entity of the effort. Our study focuses on a much smaller region, defining its mechanistic significance and the role of phosphorylation, making what we think is a significant and rigorous contribution to the field.

*M18BP1 must associate with Mis18α/β to target the complex to G1 centromeres thus it is important to understand how the complex is assembled. Previous work using size exclusion chromatography and glycerol gradient sedimentation led to the proposal that the Mis18 complex comprises a Mis18 heterotetramer (2α:2β) formed by their C-terminal coiled-coil domains bound to an unknown number of M18BP1 molecules (Nardi, et al. 2016).*

This may read fastidious, but we think that it was Stellfox et al.2016 rather than Nardi et al. 2016 who showed Mis18⟨:Mis18® complex binds directly to (a significantly larger segment of) M18BP1.

*In this work, Pan, et al. use sedimentation velocity and equilibrium ultracentrifugation to determine that the Mis18 complex comprises a Mis18 heterohexamer (4α:2β), which in turn can bind 2 copies of the M18BP1 N-terminus. The authors argue that a Mis18 hexamer is the true stoichiometry because the methods used in the previous study are more error-prone. In addition, they suggest that the previous study may have obtained a 2:2 stoichiometry because they combined a 1:1 molar ratio of separately purified Mis18α and Mis18β rather than coexpressing them in eukaryotic cells.*

*The major scientific contributions in this manuscript are 1) the biochemical characterization of the Mis18 heterohexamer which clarifies previous studies and 2) the specific M18BP1 phosphosites that regulate Mis18α/β binding. Although these contributions are worthwhile and the biochemical studies are well done it is not clear whether this work warrants publication in eLife given the relatively modest advance in our understanding of Mis18 complex function in centromere formation.*

The type of thorough and detailed work presented in this manuscript tends at time to be underappreciated by editors or reviewers on the basis that it lacks conceptual novelty. We would like to argue that this type of work is instead fair rewarding because it will provide durable, trustable information to a field that has still much to discover. In this revised version of the manuscript, we have further extended our characterization of the Mis18 complex, defining in quite some detail the basis for its oligomerization and of its interaction with M18BP1. We demonstrate that M18BP1 forms dimers or oligomers via the Mis18 complex, and that this interaction is essential for CENP-A loading, because it cannot be recapitulated simply by forcing dimerization of M18BP1 via GST.

*1) The reason for the discrepancy between the stoichiometry measured by Pan, et al. and Nardi, et al. remains unclear. By size exclusion, Nardi et al. also appear to observe a mono-dispersed species with a migration consistent with their calculated molecular weight.*

We disagree with the reviewer that Nardi et al. observed mono-dispersed species. As shown in [Figure 1](#fig1){ref-type="fig"} from Nardi et al., the one on which their hydrodynamic analysis is based, the authors only showed Western blots (WBs) of fractions from size-exclusion chromatography separations, but never showed chromatograms, nor did they show Coomassie-stained SDS-PAGE separations. It is apparent from these WBs that the indicated species often sediment or elute in more than one peak. It is our view that this evidence is incompatible with the reviewer's conclusion that the elution profiles shown by Nardi et al. represent mono-dispersed species. We also argue that putting confidence on these profiles as a source of values for the sedimentation coefficient and the Stokes' radius required to solve the Siegel-Monty equation (the approach used by Nardi et al.) may be a source of errors. In frankness, we hope that the reviewer will recognize that our approach cannot and should not be equaled to that used by Nardi and coworkers. We are confident that the new evidence we provide in this revised version of the manuscript will convince the reviewer.

*Pan, et al. argue based on their analyses that the Mis18 complex adopts an elongated conformation, leading to its earlier elution in size exclusion chromatography. Therefore, if anything I would expect a molecular weight calculation based on SEC elution of this complex to overestimate rather than underestimate its stoichiometry. In the absence of data supporting the idea that the stoichiometry of the complex is \'titratable\'.*

The reviewer should note that the equilibrium sedimentation experiments were carried out at five different concentrations (6, 4, 2, 1, and 0.5 µM) without any evidence of changes in the stoichiometry of the complex. As noted in our response to reviewer 2, equilibrium sedimentation analysis is superior because it is entirely shape independent and provides a direct measurement of mass. As explained in our response to reviewer 2, we have now extended our analysis to a version of the complex expressed in and purified from *E. coli* and show that it has the same hydrodynamic properties, at two different concentrations, of the complex purified from insect cells.

*I also don\'t find the notion that Nardi et al. observed a tetramer simply because they mixed Mis18α and Mis18β in a 1:1 ratio compelling. If the ratio were off, presumably Nardi et al. would have seen a population at equilibrium containing some hexamer and some monomer/dimer/trimer. The difference in observed species may likely be due to the different expression systems used (bacterial vs. eukaryotic) and resulting differences in protein modifications/folding/etc., but there may also be some interesting biology in the differences. On the other hand, elaborating on the technical differences between the methods to clarify why the Siegel-Monty method is more error-prone would be helpful.*

We agree with the reviewer that our argument to explain the discrepancy made assumptions that cannot be proven. We have therefore removed the sentences about 1:1 mixing from our Discussion. We already underlined the implicit difficulty of using Siegel-Monty with samples like the ones used by Nardi and co-workers. Co-expression is the gold standard to solve the solubility and assembly problems of macromolecular complexes. When writing our manuscript we have tried to be respectful of the biochemical work of Nardi et al., even if we felt that it does not meet the standards required to reach definitive conclusions. Importantly, we have not been able to purify 6His-Mis18⟨ or 6His-Mis18® in isolation from bacteria due to the very poor behavior of these proteins. Addition of an MBP tag partly solved the problem, as long as the tag was not cleaved off. As already referred to above, we have only been able to purify the Mis18 complex after co-expression of Mis18⟨ and Mis18® in *E. coli*. While not as stable as the complex produced in insect cells, this bacterially expressed complex behaves in gel filtration and AUC assays precisely like the sample produced in insect cells ([Figure 6](#fig6){ref-type="fig"}).

*I don\'t think it\'s specifically up to the authors in this paper to resolve the reason for this discrepancy, but given that it\'s not clear whether we\'re looking at precisely the same complex as in Nardi et al. I think it\'s important for the authors to provide some additional characterization of the hexamer. Is the coiled-coil domain involved in hexamerization? Do the coiled-coil mutations described by Nardi et al. affect hexamer formation? Is the hexamer comprised of a Mis18α/β tetrameric core mediated by coiled coils with additional Mis18α bound by a different mechanism (e.g., the Yippee domain, which is also used for tetramerization in SpMis18)? The Musacchio lab has made extensive use of cross-linking/mass spectrometry in the past to understand the organization of multi-protein complexes -- perhaps this could shed light on differences between the Nardi and Pan Mis18 complexes.*

As already indicated above, all our new experiments, which include experiments carried out under the conditions of Nardi et al. with protein of bacterial origin, failed to identify the existence of a Mis18 tetramer. We have now included additional evidence supporting our hexamer model. For a summary, please refer to the section of the major comment \#3 of the reviewer \#2.

*2) Although it\'s clear that Mis18 complex assembly is required for its recruitment, it is not clear whether the cell cycle timing of its recruitment is strictly determined by regulating the timing of complex assembly or whether regulation of some additional interaction plays a role. Silva, et al. found that mutating 24 putative Cdk sites (including S110 but not T40) in M18BP1 uncoupled its centromere localization from cell cycle regulation, allowing its recruitment in mitosis and G2. Can this be recapitulated by the lone S110A (or T40V/S110A) mutant characterized by Pan, et al.?*

This is a question of great interest to members of the Janssen laboratory, who have already published important work on this topic and presented at recent meetings unpublished data on the role of phosphorylation in the recruitment of CENP-A loading machinery. Partly for this reason, we have decided not to analyze this question in detail. In addition, given the very extensive level of phosphorylation of M18BP1 and other proteins in the CENP-A loading pathway, we surmise that it is unlikely that preventing the phosphorylation of the two residues we have discussed will be sufficient to bypass cell cycle inhibition of CENP-A loading. Of note, the work of Janssen and co-workers focuses precisely on this point, and reached the conclusion that lack of phosphorylation at different residues (on HJURP and M18BP1) may be sufficient to prevent CENP-A deposition in G2. More pervasive phosphorylation in M-phase may extend the regulation of additional sites, such as the ones we have identified.

[^1]: Department of Molecular Genetics, Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.
